
  
    
      
        Background_NNP
        RNA_NNP polymerase_NN II_NNP (_( pol_NN II_NNP )_) transcription_NN factor_NN TFIID_NNP
        comprises_VBZ the_DT TATA-binding_NNP protein_NN (_( TBP_NNP )_) and_CC a_DT set_NN of_IN
        TBP-associated_NNP factors_NNS (_( TAF_NNP 
        II_NNP s_VBZ )_) [_NN [_NN 1_CD 2_CD 3_CD ]_NN ]_NN ._. At_IN least_JJS 12_CD TAF_NNP 
        II_NNP s_VBZ have_VBP been_VBN identified_VBN in_IN TFIID_NNP and_CC
        cloning_VBG of_IN their_PRP$ cDNAs_NNS has_VBZ shown_VBN an_DT evolutionary_JJ
        conservation_NN of_IN TAF_NNP 
        II_NNP s_VBZ from_IN yeast_NN to_TO mammals_NNS [_NN [_NN 4_CD 5_CD 6_CD 7_CD ]_NN
        ]_NN ._. TAF_NNP 
        II_NNP s_VBZ are_VBP not_RB only_RB components_NNS of_IN the_DT
        TFIID_NNP complex_NN ,_, but_CC a_DT subset_NN of_IN TAF_NNP 
        II_NNP s_VBZ are_VBP also_RB found_VBN in_IN the_DT SAGA_NNP ,_, PCAF_NNP ,_,
        TFTC_NNP /_NN STAGA_NNP complexes_NNS which_WDT lack_VBP TBP_NNP [_NN [_NN 8_CD 9_CD 10_CD 11_CD 12_CD ]_NN
        ]_NN ._.
        TAF_NNP 
        II_NNP function_NN in_IN living_VBG cells_NNS has_VBZ been_VBN
        studied_VBN in_IN yeast_NN where_WRB the_DT use_NN of_IN temperature_NN sensitive_JJ
        (_( TS_NNP )_) mutants_NNS has_VBZ shown_VBN that_IN many_JJ TAF_NNP 
        II_NNP s_VBZ are_VBP required_VBN for_IN transcription_NN of_IN
        the_DT majority_NN of_IN yeast_NN genes_NNS [_NN [_NN 13_CD 14_CD 15_CD 16_CD 17_CD ]_NN ]_NN ._. In_IN
        contrast_NN ,_, TS_NNP lesions_NNS in_IN TAF_NNP 
        II_NNP 145_CD ,_, TAF_NNP 
        II_NNP 150_CD ,_, and_CC TAF_NNP 
        II_NNP 90_CD have_VBP a_DT less_RBR dramatic_JJ effect_NN
        affecting_VBG the_DT expression_NN of_IN only_RB a_DT specific_JJ subset_NN of_IN genes_NNS
        mainly_RB involved_VBN in_IN the_DT cell_NN cycle_NN [_NN [_NN 18_CD 19_CD ]_NN ]_NN (_( for_IN
        reviews_NNS see_VBP [_NN 3_CD ,_, 20_CD ]_NN ._.
        In_IN mammalian_JJ cells_NNS ,_, a_DT TS_NNP mutation_NN in_IN TAF_NNP 
        II_NNP 250_CD shows_VBZ that_IN one_CD of_IN the_DT functions_NNS
        of_IN this_DT protein_NN is_VBZ cell_NN cycle_NN regulation_NN [_NN [_NN 21_CD 22_CD 23_CD 24_CD ]_NN
        ]_NN ._. Genetic_NNP experiments_NNS indicate_VBP that_IN TAF_NNP 
        II_NNP 30_CD is_VBZ required_VBN for_IN the_DT viability_NN of_IN
        mouse_NN F_NN 9_CD embryonal_NN carcinoma_NN cells_NNS as_RB well_RB as_IN for_IN their_PRP$
        differentiation_NN into_IN parietal_NN endoderm_NN [_NN 25_CD ]_NN ._. In_IN the_DT
        absence_NN of_IN TAF_NNP 
        II_NNP 30_CD ,_, undifferentiated_JJ F_NN 9_CD cells_NNS die_VBP
        through_IN apoptosis_NNS ,_, but_CC TAF_NNP 
        II_NNP 30_CD is_VBZ not_RB required_VBN for_IN survival_NN of_IN
        retinoic_JJ acid_NN differentiated_JJ F_NN 9_CD cells_NNS ._.
        Several_JJ studies_NNS have_VBP also_RB focused_VBN on_IN TAF_NNP 
        II_NNP 135_CD ._. TAF_NNP 
        II_NNP 135_CD comprises_VBZ 1083_CD amino_JJ acids_NNS and_CC
        contains_VBZ multiple_JJ functional_JJ domains_NNS ._. At_IN least_JJS four_CD
        glutamine-rich_JJ domains_NNS have_VBP been_VBN described_VBN ._. Sp_NNP 1_CD and_CC CREB_NNP
        interact_NN with_IN distinct_JJ glutamine-rich_JJ domains_NNS of_IN TAF_NNP 
        II_NNP 135_CD and_CC TAF_NNP 
        II_NNP 135_CD acts_NNS as_IN a_DT coactivator_NN 
        in_IN vitro_NN for_IN these_DT activators_NNS ._. In_IN
        transfected_JJ cells_NNS ,_, subdomains_NNS of_IN TAF_NNP 
        II_NNP 135_CD can_MD act_VB as_IN dominant_JJ negative_JJ
        repressors_NNS of_IN CREB_NNP activity_NN [_NN [_NN 26_CD 27_CD 28_CD ]_NN ]_NN ._. It_PRP has_VBZ
        further_RBR been_VBN suggested_VBN that_IN some_DT neurodegenerative_JJ diseases_NNS
        may_MD result_VB from_IN sequestration_NN of_IN TAF_NNP 
        II_NNP 135_CD by_IN expanded_VBN polyglutamine_NN domains_NNS
        and_CC consequent_JJ interference_NN with_IN CREB_NNP activity_NN [_NN 29_CD ]_NN ._. TAF_NNP 
        II_NNP 135_CD also_RB contains_VBZ two_CD conserved_JJ
        regions_NNS ,_, CR-I_NNP and_CC CR-II_NNP ,_, which_WDT are_VBP shared_VBN with_IN the_DT 
        Drosophila_NNP homologue_NN dTAF_NN 
        II_NNP 110_CD and_CC mammalian_JJ TAF_NNP 
        II_NNP 105_CD [_NN 27_CD ,_, 30_CD ]_NN The_DT CR-II_NNP region_NN is_VBZ
        also_RB shared_VBN with_IN the_DT yeast_NN homologue_NN yTAF_NN 
        II_NNP 48_CD [_NN 31_CD ,_, 32_CD ]_NN and_CC contains_VBZ a_DT histone_NN
        fold_VB domain_NN required_VBN for_IN heterodimerisation_NN with_IN hTAF_NN 
        II_NNP 20_CD /_NN yTAF_NN 
        II_NNP 68_CD [_NN 33_CD ,_, 34_CD ]_NN ._. The_DT CR-II_NNP domain_NN plays_VBZ
        an_DT essential_JJ role_NN in_IN the_DT ability_NN of_IN TAF_NNP 
        II_NNP 135_CD to_TO potentiate_NN ligand-dependent_JJ
        transactivation_NN by_IN the_DT the_DT receptor_NN for_IN all-trans_JJ retinoic_JJ
        acid_NN (_( RAR_NNP )_) in_IN transfected_JJ mammalian_JJ cells_NNS [_NN 5_CD ,_, 33_CD ]_NN ._. Aside_RB
        from_IN these_DT studies_NNS ,_, little_JJ is_VBZ known_VBN concerning_VBG the_DT role_NN of_IN
        TAF_NNP 
        II_NNP 135_CD in_IN more_RBR physiological_JJ
        situations_NNS ._.
        An_DT increasing_VBG body_NN of_IN evidence_NN indicates_VBZ that_WDT targeted_VBD
        26_CD S_NNP proteasome-mediated_JJ proteolysis_NNS of_IN transcription_NN
        factors_NNS is_VBZ an_DT integral_JJ part_NN of_IN the_DT transactivation_NN process_NN ._.
        There_EX is_VBZ a_DT very_RB tight_JJ relationship_NN between_IN the_DT potency_NN of_IN
        activation_NN domains_NNS and_CC their_PRP$ stability_NN [_NN [_NN 35_CD 36_CD 37_CD 38_CD ]_NN ]_NN ._.
        Activation_NNP domains_NNS and_CC sequences_NNS required_VBN for_IN degradation_NN
        overlap_VB and_CC mutations_NNS in_IN the_DT VP_NNP 16_CD activation_NN domain_NN which_WDT
        impair_VB its_PRP$ function_NN result_NN in_IN enhanced_JJ protein_NN stability_NN [_NN
        35_CD ]_NN ._. Similarly_RB ,_, ligand-dependent_JJ targeted_VBN proteolysis_NNS of_IN
        several_JJ nuclear_JJ receptors_NNS has_VBZ been_VBN observed_VBN [_NN [_NN 39_CD 40_CD 41_CD 42_CD
        ]_NN ]_NN ._. In_IN the_DT estrogen_NN receptor_NN ,_, the_DT RARα_NNP ,_, and_CC the_DT RXRα_NNP ,_,
        deletion_NN of_IN the_DT α-helix_JJ H_NNP 12_CD of_IN the_DT ligand_NN binding_JJ domain_NN
        which_WDT is_VBZ essential_JJ for_IN ligand-dependent_JJ activation_NN
        stabilises_NNS these_DT proteins_NNS showing_VBG that_IN proteolysis_NNS and_CC
        transactivation_NN are_VBP intimately_RB linked_VBN [_NN [_NN 42_CD 43_CD 44_CD ]_NN ]_NN ._. In_IN
        the_DT case_NN of_IN nuclear_JJ receptors_NNS ,_, their_PRP$ targeted_VBN proteolysis_NNS
        in_IN the_DT presence_NN of_IN ligand_NN may_MD be_VB a_DT mechanism_NN for_IN
        attenuating_VBG the_DT physiological_JJ response_NN to_TO the_DT ligand_NN ._. It_PRP
        has_VBZ also_RB been_VBN suggested_VBN that_WDT targeted_VBD proteolysis_NNS is_VBZ a_DT
        means_NN of_IN regulating_VBG other_JJ physiological_JJ responses_NNS ,_, such_JJ as_IN
        signaling_VBG through_IN STAT_NNP factors_NNS [_NN 45_CD ]_NN and_CC heat_NN shock_NN [_NN
        46_CD ]_NN ._.
        Although_IN targeted_VBN proteolysis_NNS of_IN transcriptional_NN
        activators_NNS has_VBZ been_VBN investigated_VBN ,_, it_PRP is_VBZ not_RB known_VBN whether_IN
        components_NNS of_IN the_DT basal_NN transcription_NN apparatus_NN are_VBP subject_JJ
        to_TO this_DT type_NN of_IN regulation_NN in_IN response_NN to_TO physiological_JJ
        stimuli_NNS ._. We_PRP show_VBP here_RB that_IN TBP_NNP and_CC TAF_NNP 
        II_NNP 135_CD are_VBP selectively_RB depleted_VBN in_IN
        extracts_NNS from_IN T-RA_NNP differentiated_JJ F_NN 9_CD cells_NNS and_CC from_IN
        differentiated_JJ C_NNP 2_CD C_NNP 12_CD cells_NNS ._. This_DT depletion_NN is_VBZ due_JJ to_TO the_DT
        selective_JJ targeting_VBG of_IN TBP_NNP and_CC TAF_NNP 
        II_NNP 135_CD for_IN proteolytic_JJ degradation_NN since_IN
        depletion_NN is_VBZ blocked_VBN when_WRB cells_NNS are_VBP treated_VBN with_IN proteasome_NN
        inhibitors_NNS ._. During_IN F_NN 9_CD cell_NN differentiation_NN ,_, degradation_NN of_IN
        TBP_NNP and_CC TAF_NNP 
        II_NNP 135_CD is_VBZ concomitant_NN with_IN that_DT of_IN the_DT
        RARγ_NNP 2_CD ,_, a_DT critical_JJ activator_NN in_IN primitive_JJ endoderm_NN
        differentiation_NN ._. These_DT results_NNS reveal_VBP a_DT novel_NN pathway_NN
        controlling_VBG the_DT intracellular_NN levels_NNS of_IN these_DT two_CD TFIID_NNP
        components_NNS and_CC show_NN that_IN in_IN F_NN 9_CD cells_NNS RA_NNP not_RB only_RB induces_VBZ
        targeted_VBN proteolysis_NNS of_IN the_DT RARγ_NNP 2_CD ,_, but_CC also_RB of_IN the_DT basal_NN
        transcription_NN factors_NNS which_WDT mediate_VB transcriptional_NN
        activation_NN ._. We_PRP further_JJ show_NN that_IN stable_JJ ectopic_JJ expression_NN
        of_IN TAF_NNP 
        II_NNP 135_CD in_IN F_NN 9_CD cells_NNS delays_VBZ the_DT targeted_VBN
        degradation_NN of_IN endogenous_JJ TAF_NNP 
        II_NNP 135_CD ,_, TBP_NNP ,_, and_CC the_DT RARγ_NNP 2_CD in_IN response_NN
        to_TO T-RA_NNP ._. The_DT cells_NNS have_VBP an_DT enhanced_JJ growth_NN rate_NN and_CC their_PRP$
        differentiation_NN into_IN primitive_JJ endoderm_NN is_VBZ impaired_VBN at_IN an_DT
        early_JJ stage_NN ,_, but_CC they_PRP readily_RB differentiate_VB into_IN parietal_NN
        endoderm_NN ._. Treatment_NNP of_IN these_DT cells_NNS with_IN T-RA_NNP also_RB induces_VBZ
        the_DT appearance_NN of_IN a_DT population_NN of_IN cells_NNS with_IN an_DT atypical_JJ
        elongated_JJ morphology_NN ,_, distinct_JJ from_IN that_DT of_IN the_DT primitive_JJ
        endodermal_NN cells_NNS ,_, which_WDT have_VBP not_RB been_VBN previously_RB documented_VBN
        with_IN wild_JJ type_NN F_NN 9_CD cells_NNS ,_, and_CC which_WDT are_VBP resistant_JJ to_TO
        differentiation_NN with_IN bt_NN 2_CD cAMP_NN ._.
      
      
        Results_NNS
        
          TBP_NNP and_CC TAF_NNP II_NNP 135_CD are_VBP selectively_RB depleted_VBN in_IN
          extracts_NNS from_IN T-RA_NNP differentiated_JJ F_NN 9_CD cells_NNS
          F_NN 9_CD cells_NNS are_VBP a_DT well_RB characterised_JJ model_NN for_IN cellular_JJ
          differentiation_NN ._. In_IN the_DT presence_NN of_IN T-RA_NNP ,_, F_NN 9_CD cells_NNS
          differentiate_VB into_IN primitive_JJ or_CC visceral_NN endoderm_NN ,_, and_CC
          into_IN parietal_NN endoderm_NN in_IN the_DT presence_NN of_IN T-RA_NNP and_CC bt_NN 
          2_CD cAMP_NN [_NN [_NN 47_CD 48_CD ]_NN ]_NN ._. Differentiation_NNP
          is_VBZ accompanied_VBN by_IN growth_NN inhibition_NN ,_, characteristic_JJ
          changes_NNS in_IN cell_NN morphology_NN ,_, targeted_VBN degradation_NN of_IN
          RARγ_NNP 2_CD ,_, induction_NN of_IN marker_NN genes_NNS ,_, and_CC increased_VBD
          apoptosis_NNS ._.
          To_TO determine_VB whether_IN components_NNS of_IN basal_NN transcription_NN
          factor_NN TFIID_NNP were_VBD subject_JJ to_TO regulation_NN during_IN F_NN 9_CD cell_NN
          differentiation_NN ,_, immunoblotting_VBG with_IN monoclonal_NN
          antibodies_NNS against_IN TBP_NNP and_CC a_DT number_NN of_IN TAF_NNP 
          II_NNP s_VBZ ,_, was_VBD used_VBN to_TO monitor_VB the_DT levels_NNS
          of_IN the_DT respective_JJ proteins_NNS in_IN differentiated_JJ cell_NN
          extracts_NNS (_( see_VB Materials_NNPS and_CC Methods_NNP )_) ._.
          No_DT significant_JJ changes_NNS in_IN the_DT levels_NNS of_IN TAF_NNP 
          II_NNP 100_CD ,_, TAF_NNP 
          II_NNP 55_CD ,_, TAF_NNP 
          II_NNP 20_CD ,_, TAF_NNP 
          II_NNP 30_CD ,_, and_CC TAF_NNP 
          II_NNP 18_CD ,_, or_CC the_DT largest_JJS subunit_NN of_IN RNA_NNP
          polymerase_NN II_NNP were_VBD observed_VBN between_IN 3_CD and_CC 10_CD days_NNS of_IN T-RA_NNP
          treatment_NN (_( Fig_NNP ._. 1_LS A_DT ,_, lanes_NNS 1_CD -_: 6_CD and_CC data_NNS not_RB shown_VBN )_) ._. In_IN
          striking_JJ contrast_NN ,_, TAF_NNP 
          II_NNP 135_CD and_CC TBP_NNP were_VBD strongly_RB and_CC
          selectively_RB depleted_VBN in_IN extracts_NNS made_VBN from_IN cells_NNS
          differentiated_JJ with_IN T-RA_NNP for_IN more_JJR than_IN 3_CD days_NNS (_( Fig_NNP ._.
          1_LS Alanes_NNP 1_CD -_: 2_LS )_) and_CC remained_VBD at_IN low_JJ levels_NNS up_RB until_IN at_IN least_JJS
          day_NN 10_CD (_( lanes_NNS 2_CD -_: 5_LS )_) ._. No_DT such_JJ changes_NNS were_VBD observed_VBN in_IN
          vehicle_NN treated_VBD control_NN cultures_NNS (_( Fig_NNP ._. 1_LS A_DT ,_, lanes_NNS 7_CD -_: 12_CD )_) ._.
          In_IN these_DT experiments_NNS ,_, TAF_NNP 
          II_NNP 135_CD and_CC TBP_NNP were_VBD detected_VBN using_VBG two_CD
          different_JJ monoclonal_NN antibodies_NNS directed_VBN against_IN distinct_JJ
          epitopes_NNS (_( see_VB Materials_NNPS and_CC methods_NNS )_) ._. The_DT relevant_JJ
          extracts_NNS from_IN T-RA_NNP treated_VBD cells_NNS were_VBD also_RB analysed_JJ by_IN
          staining_VBG with_IN Coomassie_NNP Brilliant_NNP Blue_NNP showing_VBG that_IN there_EX
          was_VBD no_DT overall_JJ change_NN in_IN the_DT protein_NN profile_NN (_( Fig_NNP ._. 1_LS B_NNP )_) ._.
          Therefore_RB ,_, there_EX is_VBZ a_DT selective_JJ depletion_NN of_IN these_DT two_CD
          TFIID_NNP components_NNS in_IN extracts_NNS from_IN differentiating_VBG
          cells_NNS ._.
          To_TO evaluate_VB the_DT levels_NNS of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD in_IN extracts_NNS from_IN primitive_JJ
          endodermal_NN cells_NNS we_PRP performed_VBD titration_NN experiments_NNS using_VBG
          serial_NN dilutions_NNS of_IN undifferentiated_JJ F_NN 9_CD cell_NN extract_NN ._.
          Upon_IN prolonged_JJ exposure_NN ,_, TAF_NNP 
          II_NNP 135_CD could_MD still_RB be_VB detected_VBN in_IN a_DT
          20_CD -_: fold_VB dilution_NN of_IN the_DT F_NN 9_CD cell_NN extract_NN ,_, whereas_IN it_PRP was_VBD
          virtually_RB undetectable_JJ in_IN extracts_NNS from_IN day_NN 7_CD
          differentiated_JJ cells_NNS (_( Fig_NNP ._. 1_LS C_NNP ,_, lanes_NNS 1_CD -_: 5_CD compared_VBN with_IN
          lane_NN 6_CD )_) ._. Similarly_RB ,_, TBP_NNP was_VBD readily_RB detected_VBN in_IN the_DT
          20_CD -_: fold_VB dilution_NN of_IN F_NN 9_CD cell_NN extract_NN ,_, while_IN the_DT levels_NNS
          detected_VBD in_IN the_DT differentiated_JJ cell_NN extracts_NNS were_VBD
          significantly_RB lower_JJR (_( compare_VB lanes_NNS 5_CD and_CC 6_CD )_) ._.
          The_DT above_IN experiments_NNS were_VBD performed_VBN with_IN total_JJ cell_NN
          extracts_NNS made_VBN in_IN the_DT presence_NN of_IN 0_CD ._. 5_CD M_NNP KCl_NNP ._. We_PRP also_RB asked_VBD
          whether_IN the_DT depletion_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD would_MD be_VB observed_VBN in_IN nuclear_JJ
          extracts_NNS from_IN differentiated_JJ F_NN 9_CD cells_NNS where_WRB the_DT nuclei_NN
          were_VBD extracted_VBN with_IN 1_CD ._. 0_CD M_NNP KCl_NNP to_TO ensure_VB efficient_JJ protein_NN
          extraction_NN ._. As_IN observed_VBD in_IN total_JJ cell_NN extracts_NNS ,_, TAF_NNP 
          II_NNP 135_CD and_CC TBP_NNP were_VBD selectively_RB
          depleted_VBN in_IN nuclear_JJ extracts_NNS from_IN differentiated_JJ cells_NNS
          (_( Fig_NNP ._. 1_LS D_NNP )_) ._.
          TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD were_VBD strongly_RB and_CC selectively_RB
          depleted_VBN in_IN extracts_NNS from_IN visceral_NN endoderm_NN
          differentiated_JJ F_NN 9_CD cells_NNS analogous_JJ to_TO what_WP was_VBD observed_VBN in_IN
          primitive_JJ endodermal_NN cells_NNS (_( data_NNS not_RB shown_VBN )_) ._. When_WRB F_NN 9_CD
          cells_NNS were_VBD treated_VBN with_IN T-RA_NNP and_CC bt_NN 
          2_CD cAMP_NN to_TO induce_VB parietal_NN endoderm_NN
          differentiation_NN ,_, a_DT selective_JJ depletion_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD also_RB took_VBD place_NN between_IN day_NN 3_CD
          and_CC day_NN 5_CD (_( Fig_NNP ._. 1_LS Elanes_NNP 1_CD ,_, 2_CD and_CC 6_CD )_) ,_, however_RB ,_, TBP_NNP ,_, but_CC
          not_RB TAF_NNP 
          II_NNP 135_CD ,_, reappeared_JJ in_IN parietal_NN
          endodermal_NN cell_NN extracts_NNS around_IN day_NN 9_CD (_( lanes_NNS 4_CD -_: 5_LS )_) ._.
          Together_RB the_DT above_JJ results_NNS indicate_VBP that_IN there_EX is_VBZ a_DT
          specific_JJ regulation_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD during_IN F_NN 9_CD cell_NN
          differentiation_NN ._.
        
        
          Depletion_NNP of_IN TBP_NNP and_CC TAF_NNP II_NNP 135_CD is_VBZ not_RB observed_VBN in_IN
          F_NN 9_CD cells_NNS which_WDT are_VBP refractory_JJ to_TO T-RA_NNP ._.
          To_TO determine_VB whether_IN the_DT depletion_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD was_VBD intimately_RB linked_VBN to_TO the_DT
          differentiation_NN process_NN ,_, we_PRP examined_VBD the_DT regulation_NN of_IN
          these_DT proteins_NNS in_IN mutant_JJ F_NN 9_CD cells_NNS with_IN altered_VBN
          differentiation_NN properties_NNS ._. F_NN 9_CD cells_NNS in_IN which_WDT the_DT
          retinoid_NN X_NNP receptor_NN α_NN gene_NN has_VBZ been_VBN disrupted_VBN by_IN
          homologous_RB recombination_NN (_( RXRα_NNP -_: /_NN -_: cells_NNS )_) are_VBP impaired_VBN in_IN
          their_PRP$ response_NN to_TO T-RA_NNP [_NN 49_CD ]_NN ._. When_WRB these_DT cells_NNS are_VBP
          treated_VBN with_IN T-RA_NNP ,_, the_DT depletion_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD observed_VBD in_IN the_DT cell_NN extracts_NNS
          is_VBZ delayed_VBN by_IN almost_RB 4_CD days_NNS and_CC takes_VBZ place_NN only_RB between_IN
          days_NNS 7_CD and_CC 9_CD rather_RB than_IN between_IN days_NNS 3_CD and_CC 5_CD in_IN
          wild-type_JJ cells_NNS (_( Fig_NNP ._. 2_LS A_DT )_) ,_, while_IN no_DT such_JJ depletion_NN is_VBZ
          seen_VBN in_IN extracts_NNS from_IN vehicle_NN treated_VBD cells_NNS (_( Fig_NNP ._. 2_LS B_NNP )_) ._. In_IN
          contrast_NN ,_, no_DT significant_JJ change_NN in_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD is_VBZ seen_VBN in_IN extracts_NNS from_IN T-RA_NNP
          treated_VBD RXRα_NNP -_: /_NN -_: RARγ_NNP -_: /_NN -_: cells_NNS ,_, in_IN which_WDT the_DT RARγ_NNP gene_NN has_VBZ
          also_RB been_VBN disrupted_VBN [_NN 50_CD ,_, 51_CD ]_NN and_CC which_WDT are_VBP known_VBN to_TO be_VB
          refractory_JJ to_TO T-RA_NNP induced_VBD differentiation_NN (_( Fig_NNP ._. 2_LS C_NNP )_) ._.
          Thus_RB ,_, the_DT selective_JJ depletion_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD requires_VBZ that_IN the_DT F_NN 9_CD cells_NNS
          respond_VBP ,_, at_IN least_JJS partially_RB ,_, to_TO T-RA_NNP ,_, but_CC does_VBZ not_RB
          require_VB full_JJ differentiation_NN to_TO take_VB place_NN ._.
        
        
          Depletion_NNP of_IN TBP_NNP and_CC TAF_NNP II_NNP 135_CD is_VBZ due_JJ to_TO targeted_VBN
          proteolytic_JJ degradation_NN
          The_DT depletion_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD in_IN extracts_NNS from_IN day_NN 3_CD -_: 10_CD T-RA_NNP
          treated_VBD cells_NNS could_MD result_VB from_IN transcriptional_NN or_CC
          post-transcriptional_JJ events_NNS ._. Semi-quantitative_NNP
          reverse-transcription_JJ PCR_NNP (_( RT-PCR_NNP )_) experiments_NNS using_VBG
          exon-specific_JJ oligonucleotide_NN primers_NNS showed_VBD that_IN there_EX
          were_VBD no_DT significant_JJ changes_NNS in_IN the_DT TAF_NNP 
          II_NNP 135_CD or_CC TBP_NNP mRNA_NN levels_NNS during_IN
          differentiation_NN (_( data_NNS not_RB shown_VBN )_) ._. This_DT suggests_VBZ that_DT
          disappearance_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD in_IN extracts_NNS from_IN differentiated_JJ
          cells_NNS does_VBZ not_RB occur_VB at_IN the_DT transcriptional_NN level_NN ,_, but_CC
          rather_RB results_VBZ from_IN a_DT post-transcriptional_JJ event_NN ._.
          The_DT peptide_NN aldehyde_NN proteasome_NN inhibitors_NNS MG_NNP 132_CD and_CC
          ALLN_NNP have_VBP previously_RB been_VBN used_VBN to_TO investigate_VB the_DT
          post-transcriptional_JJ regulation_NN of_IN proteins_NNS during_IN
          physiological_JJ processes_VBZ [_NN 52_CD ,_, 53_CD ]_NN ._. To_TO determine_VB whether_IN
          the_DT depletion_NN of_IN TAF_NNP 
          II_NNP 135_CD and_CC TBP_NNP observed_VBD in_IN the_DT
          extracts_NNS from_IN late_JJ T-RA_NNP treated_VBD F_NN 9_CD cells_NNS was_VBD due_JJ to_TO their_PRP$
          selective_JJ proteolysis_NNS ,_, we_PRP treated_VBD T-RA_NNP differentiated_JJ
          cells_NNS with_IN these_DT inhibitors_NNS on_IN days_NNS 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD ,_, and_CC 7_CD ._.
          After_IN an_DT overnight_JJ exposure_NN ,_, extracts_NNS were_VBD prepared_VBN (_( day_NN
          4_CD ,_, 5_CD ,_, 6_CD ,_, 7_CD and_CC 8_CD extracts_NNS in_IN Figs_NNP ._. 3_LS Aand_NNP 3_CD B_NNP )_) ._. In_IN the_DT
          absence_NN of_IN MG_NNP 132_CD or_CC ALLN_NNP ,_, TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD disappeared_VBD in_IN the_DT
          differentiated_JJ cell_NN extracts_NNS (_( middle_JJ panel_NN Figs_NNP ._. 3_LS Aand_NNP
          3_CD Blanes_NNP 6_CD -_: 10_CD )_) ._. In_IN contrast_NN ,_, in_IN the_DT presence_NN of_IN the_DT
          inhibitors_NNS both_DT proteins_NNS were_VBD readily_RB detected_VBN even_RB at_IN
          late_JJ times_NNS where_WRB they_PRP are_VBP normally_RB not_RB observed_VBD (_( lanes_NNS
          1_CD -_: 5_LS )_) ._. The_DT levels_NNS were_VBD nevertheless_RB lower_JJR than_IN those_DT
          detected_VBN in_IN undifferentiated_JJ cell_NN extracts_NNS ._. The_DT level_NN of_IN
          TAF_NNP 
          II_NNP 55_CD ,_, which_WDT remains_VBZ constant_JJ during_IN
          differentiation_NN ,_, is_VBZ only_RB mildly_RB increased_VBN by_IN the_DT addition_NN
          of_IN MG_NNP 132_CD or_CC ALLN_NNP (_( Figs_NNP ._. 3_LS Aand_NNP 3_CD Blower_NNP panel_NN ,_, lanes_NNS 1_CD -_: 5_CD
          and_CC 6_CD -_: 10_CD )_) ._. The_DT addition_NN of_IN MG_NNP 132_CD or_CC ALLN_NNP to_TO
          non-differentiated_JJ cells_NNS also_RB resulted_VBD in_IN only_RB a_DT small_JJ
          increase_NN in_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD levels_NNS (_( Figs_NNP ._. 3_LS Aand_NNP 3_CD B_NNP ,_, top_JJ
          panel_NN compare_VB lanes_NNS 1_CD -_: 5_CD and_CC 6_CD -_: 10_CD )_) ._. The_DT above_IN results_NNS
          indicate_VBP that_IN when_WRB proteolysis_NNS is_VBZ inhibited_VBD the_DT depletion_NN
          of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD is_VBZ no_RB longer_RB observed_VBD showing_VBG
          that_IN it_PRP is_VBZ due_JJ to_TO T-RA-_NNP induced_VBD proteolytic_JJ
          degradation_NN ._.
          We_PRP also_RB prepared_VBD extracts_NNS from_IN differentiated_JJ cells_NNS
          where_WRB MG_NNP 132_CD was_VBD added_VBN only_RB at_IN the_DT time_NN of_IN extract_NN
          preparation_NN ._. Extracts_NNP made_VBD in_IN this_DT way_NN are_VBP a_DT measure_NN of_IN
          the_DT intracellular_NN level_NN of_IN these_DT proteins_NNS since_IN synthesis_NN
          and_CC degradation_NN are_VBP both_DT stopped_VBN at_IN the_DT same_JJ time_NN ._.
          Comparison_NNP of_IN the_DT TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD levels_NNS in_IN extracts_NNS from_IN day_NN 7_CD
          differentiated_JJ cells_NNS prepared_VBN in_IN the_DT presence_NN of_IN MG_NNP 132_CD
          showed_VBD that_IN they_PRP were_VBD indeed_RB significantly_RB reduced_VBN
          compared_VBN to_TO undifferentiated_JJ cells_NNS or_CC day_NN 3_CD
          differentiated_JJ cells_NNS (_( approximately_RB 3_CD fold_VB ,_, Fig_NNP ._. 3_LS C_NNP ,_,
          lanes_NNS 1_CD ,_, 4_CD and_CC 5_CD ,_, similar_JJ results_NNS were_VBD obtained_VBN in_IN the_DT
          presence_NN of_IN ALLN_NNP data_NNS not_RB shown_VBN )_) ._. Nevertheless_RB ,_, these_DT
          proteins_NNS do_VBP not_RB disappear_VB completely_RB as_IN they_PRP do_VBP in_IN the_DT
          absence_NN of_IN MG_NNP 132_CD (_( lanes_NNS 2_CD -_: 3_LS )_) ._. Therefore_RB ,_, the_DT complete_JJ
          disappearance_NN of_IN these_DT proteins_NNS seen_VBN in_IN the_DT absence_NN of_IN
          protease_NN inhibitors_NNS indicates_VBZ that_IN there_EX is_VBZ further_JJ
          degradation_NN in_IN the_DT extracts_NNS which_WDT exaggerates_NNS the_DT
          differences_NNS between_IN differentiated_JJ and_CC undifferentiated_JJ
          cells_NNS ._. Although_IN ,_, less_JJR TBP_NNP could_MD be_VB immunopurified_JJ from_IN
          the_DT MG_NNP 132_CD blocked_VBN differentiated_JJ cell_NN extracts_NNS using_VBG the_DT
          anti-_NN TBP_NNP antidody_NN 2_CD C_NNP 1_CD ,_, when_WRB equal_JJ amounts_NNS of_IN
          immunopurified_JJ TBP_NNP from_IN differentiated_JJ and_CC
          undifferentiated_JJ cells_NNS was_VBD loaded_VBN ,_, equivalent_NN amonts_NNS of_IN
          TAF_NNP 
          II_NNP 135_CD were_VBD detected_VBN in_IN the_DT TFIIDs_NNP
          (_( data_NNS not_RB shown_VBN )_) ._. Thus_RB ,_, while_IN the_DT overall_JJ level_NN of_IN TFIID_NNP
          is_VBZ diminished_VBN through_IN the_DT reduction_NN in_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD ,_, the_DT relative_JJ stoichiometry_NN of_IN
          the_DT remaining_VBG TFIID_NNP is_VBZ not_RB significantly_RB altered_VBN ._. The_DT
          apparently_RB larger_JJR decrease_NN in_IN TAF_NNP 
          II_NNP 135_CD seen_VBN in_IN Fig_NNP ._. 3_LS Cresults_NNP from_IN the_DT
          lower_JJR efficiency_NN of_IN the_DT antibody_NN (_( see_VB also_RB Fig_NNP ._. 1_LS C_NNP ._. )_)
          Taken_VBN altogether_RB ,_, the_DT above_JJ results_NNS show_VBP that_IN the_DT
          intracellular_NN level_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD and_CC consequently_RB TFIID_NNP is_VBZ
          significantly_RB reduced_VBN in_IN differentiated_JJ cells_NNS through_IN
          T-RA-_NNP induced_VBD proteolytic_JJ degradation_NN ._.
        
        
          Coordinate_NNP degradation_NN of_IN TBP_NNP ,_, TAF_NNP II_NNP 135_CD ,_, and_CC the_DT
          RARgamma_NNP 2_CD receptor_NN during_IN F_NN 9_CD cell_NN differentiation_NN
          It_PRP has_VBZ previously_RB been_VBN shown_VBN that_IN the_DT RARγ_NNP 2_CD is_VBZ subject_JJ
          to_TO degradation_NN beginning_VBG 48_CD hours_NNS after_IN T-RA-_NNP induced_VBD
          differentiation_NN of_IN F_NN 9_CD cells_NNS [_NN 42_CD ]_NN ._. To_TO determine_VB whether_IN
          there_EX is_VBZ a_DT coordinate_VB degradation_NN of_IN RARγ_NNP 2_CD ,_, TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD ,_, we_PRP examined_VBD extracts_NNS made_VBN at_IN
          these_DT early_JJ times_NNS ._. After_IN 24_CD hours_NNS of_IN T-RA_NNP treament_NN the_DT
          levels_NNS of_IN RARγ_NNP 2_CD ,_, TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD were_VBD unchanged_JJ (_( Fig_NNP ._. 3_LS D_NNP ,_, lanes_NNS
          1_CD -_: 2_LS )_) ._. However_RB after_IN 48_CD hours_NNS ,_, there_EX was_VBD a_DT T-RA-_NNP dependent_JJ
          reduction_NN in_IN the_DT amount_NN of_IN RARγ_NNP 2_CD and_CC TBP_NNP and_CC a_DT
          significant_JJ shift_NN in_IN the_DT electrophoretic_JJ mobility_NN of_IN TAF_NNP 
          II_NNP 135_CD (_( lanes_NNS 3_CD -_: 4_LS )_) ._. By_IN 4_CD days_NNS the_DT
          levels_NNS of_IN all_DT three_CD proteins_NNS were_VBD strongly_RB reduced_VBN (_( lanes_NNS
          5_CD -_: 6_CD )_) ._. These_DT results_NNS indicate_VBP that_IN the_DT onset_NN of_IN
          degradation_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD is_VBZ concomitant_NN with_IN that_DT of_IN the_DT
          RARγ_NNP 2_CD suggesting_VBG that_IN these_DT events_NNS are_VBP
          interdependent_NN ._.
        
        
          Constitutive_NNP ectopic_JJ expression_NN of_IN TAF_NNP II_NNP 135_CD
          impairs_NNS F_NN 9_CD cell_NN primitive_JJ endoderm_NN differentiation_NN
          The_DT above_IN results_NNS show_VBP that_IN the_DT level_NN of_IN TAF_NNP 
          II_NNP 135_CD and_CC TBP_NNP is_VBZ strictly_RB controlled_VBN
          during_IN the_DT differentiation_NN of_IN F_NN 9_CD cells_NNS by_IN a_DT
          post-transcriptional_JJ mechanism_NN involving_VBG targeted_VBN
          proteolysis_NNS ._. To_TO test_VB whether_IN artificially_RB increasing_VBG the_DT
          level_NN of_IN TAF_NNP 
          II_NNP 135_CD would_MD affect_VB the_DT proper_JJ
          differentiation_NN of_IN F_NN 9_CD cells_NNS ,_, we_PRP established_VBD cell_NN lines_NNS
          which_WDT constitutively_RB express_VB flag-tagged_JJ versions_NNS of_IN
          human_JJ TAF_NNP 
          II_NNP 135_CD [_NN fTAF_NN 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) and_CC fTAF_NN 
          II_NNP 135_CD (_( 805_CD -_: 1083_CD )_) see_VB Materials_NNPS and_CC
          methods_NNS ]_NN ._. TAF_NNP 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) contains_VBZ all_PDT the_DT
          known_VBN functional_JJ domains_NNS ,_, but_CC lacks_VBZ an_DT unconserved_JJ
          proline-alanine-rich_JJ region_NN whereas_IN ,_, TAF_NNP 
          II_NNP 135_CD (_( 805_CD -_: 1083_CD )_) comprises_VBZ only_RB the_DT
          CR-II_NNP region_NN ._.
          For_IN fTAF_NN 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) 12_CD cell_NN lines_NNS were_VBD
          examined_VBN and_CC we_PRP chose_VBD two_CD ,_, lines_NNS A_DT and_CC B_NNP ,_, since_IN they_PRP
          expressed_VBD the_DT highest_JJS levels_NNS of_IN the_DT fTAF_NN 
          II_NNP 135_CD protein_NN ._. Immunoblotting_NNP with_IN an_DT
          anti-flag_JJ monoclonal_NN antibody_NN showed_VBD a_DT significantly_RB
          higher_JJR expression_NN level_NN in_IN line_NN A_DT compared_VBN to_TO line_VB B_NNP
          (_( Fig_NNP ._. 4_LS A_DT ,_, lanes_NNS 1_CD -_: 2_LS )_) ._. This_DT result_NN is_VBZ confirmed_VBN by_IN
          immunoblotting_VBG with_IN monoclonal_NN antibody_NN 20_CD TA_NNP which_WDT
          detects_NNS both_DT the_DT endogenous_JJ and_CC ectopically_RB expressed_VBD TAF_NNP
          
          II_NNP 135_CD proteins_NNS (_( Figs_NNP ._. 4_LS Band_NNP 4_CD C_NNP ,_, lane_NN
          1_LS )_) ._. In_IN line_NN A_DT ,_, the_DT level_NN of_IN the_DT ectopically_RB expressed_VBN
          protein_NN is_VBZ higher_JJR than_IN that_DT of_IN the_DT endogenous_JJ protein_NN ,_,
          while_IN in_IN line_NN B_NNP both_DT the_DT exogenous_JJ and_CC the_DT endogenous_JJ
          proteins_NNS are_VBP expressed_VBN at_IN similar_JJ levels_NNS ._. For_IN fTAF_NN 
          II_NNP 135_CD (_( 805_CD -_: 1083_CD )_) which_WDT contains_VBZ only_RB
          the_DT conserved_JJ C-_NNP terminal_NN domain_NN ,_, 8_CD cell_NN lines_NNS were_VBD
          examined_VBN of_IN which_WDT 3_CD expressed_VBD the_DT fTAF_NN 
          II_NNP 135_CD protein_NN (_( Fig_NNP ._. 6_CD A_DT )_) ._. Both_DT of_IN the_DT
          cell_NN lines_NNS expressing_VBG fTAF_NN 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) showed_VBD an_DT
          approximately_RB 2_CD -_: fold_VB accelerated_VBD growth_NN rate_NN compared_VBN to_TO
          wild_JJ type_NN cells_NNS while_IN no_DT significant_JJ increase_NN was_VBD seen_VBN in_IN
          the_DT fTAF_NN 
          II_NNP 135_CD (_( 805_CD -_: 1083_CD )_) expressing_VBG cells_NNS
          (_( Fig_NNP ._. 4_LS E_NNP ,_, and_CC data_NNS not_RB shown_VBN ,_, note_NN that_IN the_DT apparent_JJ
          slowing_NN of_IN growth_NN between_IN day_NN 8_CD and_CC 10_CD for_IN lines_NNS A_DT and_CC B_NNP
          is_VBZ due_JJ to_TO their_PRP$ reaching_VBG confluence_NN )_) ._.
          We_PRP first_RB verified_VBN whether_IN treatment_NN of_IN these_DT cells_NNS
          with_IN T-RA_NNP would_MD lead_VB to_TO the_DT depletion_NN of_IN the_DT ectopically_RB
          expressed_VBN TAF_NNP 
          II_NNP 135_CD ._. In_IN line_NN A_DT ,_, both_DT the_DT
          ectopically_RB expressed_VBN TAF_NNP 
          II_NNP 135_CD and_CC the_DT endogenous_JJ TAF_NNP 
          II_NNP 135_CD were_VBD depleted_VBN with_IN the_DT same_JJ
          kinetics_NNS (_( Fig_NNP ._. 4_LS B_NNP ,_, lanes_NNS 1_CD -_: 5_LS )_) ._. TBP_NNP was_VBD also_RB concomitantly_RB
          depleted_VBN in_IN these_DT extracts_NNS ,_, and_CC all_DT three_CD proteins_NNS were_VBD
          stabilised_JJ when_WRB cells_NNS were_VBD treated_VBN with_IN MG_NNP 132_CD (_( lanes_NNS
          6_CD -_: 8_CD )_) ._. Importantly_NNP however_RB ,_, the_DT disappearance_NN of_IN all_DT three_CD
          proteins_NNS was_VBD clearly_RB delayed_VBN by_IN 48_CD hours_NNS compared_VBN to_TO
          wild-type_JJ cells_NNS (_( compare_VB Figs_NNP ._. 4_LS Band_NNP Fig_NNP ._. 1_LS Aor_NNP Fig_NNP ._. 3_LS C_NNP )_) ._.
          In_IN line_NN B_NNP ,_, there_EX was_VBD also_RB coordinate_VB disappearance_NN of_IN TBP_NNP
          and_CC the_DT exogenous_JJ and_CC endogenous_JJ TAF_NNP 
          II_NNP 135_CD (_( Fig_NNP ._. 4_LS C_NNP )_) ,_, although_IN no_DT obvious_JJ
          delay_NN such_JJ as_IN that_DT seen_VBN in_IN line_NN A_DT is_VBZ observed_VBN ._. In_IN
          contrast_NN ,_, no_DT depletion_NN of_IN fTAF_NN 
          II_NNP 135_CD (_( 805_CD -_: 1083_CD )_) was_VBD seen_VBN following_VBG
          T-RA_NNP treatment_NN ,_, while_IN the_DT endogenous_JJ TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD were_VBD depleted_VBN normally_RB between_IN
          days_NNS 3_CD and_CC 5_CD (_( Fig_NNP ._. 6_CD B_NNP ,_, and_CC data_NNS not_RB shown_VBN )_) ._.
          As_IN the_DT targeted_VBN proteolysis_NNS of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD is_VBZ linked_VBN to_TO the_DT
          differentiation_NN process_NN ,_, the_DT delayed_VBN depletion_NN in_IN line_NN A_DT
          suggests_VBZ that_IN T-RA_NNP induced_VBD differentiation_NN may_MD be_VB
          perturbed_VBD ._. Their_PRP$ differentiation_NN was_VBD therefore_RB compared_VBN
          to_TO that_DT of_IN the_DT wild-type_JJ cells_NNS ._.
          In_IN wild_JJ type_NN cells_NNS ,_, the_DT degradation_NN of_IN RARγ_NNP 2_CD begins_VBZ at_IN
          day_NN 2_CD and_CC the_DT protein_NN is_VBZ strongly_RB depleted_VBN from_IN extracts_NNS
          made_VBN at_IN day_NN 3_CD (_( Fig_NNP ._. 4_LS D_NNP ,_, lane_NN 3_LS )_) ._. At_IN later_JJ times_NNS ,_, low_JJ
          levels_NNS of_IN only_RB the_DT unphosphorylated_JJ form_NN of_IN RARγ_NNP 2_CD can_MD be_VB
          seen_VBN in_IN the_DT extracts_NNS (_( lanes_NNS 4_CD -_: 6_CD )_) ._. In_IN contrast_NN ,_, in_IN line_NN A_DT ,_,
          elevated_VBD levels_NNS of_IN RARγ_NNP 2_CD are_VBP observed_VBN even_RB at_IN day_NN 5_CD (_( Fig_NNP ._.
          4_LS D_NNP ,_, lanes_NNS 3_CD -_: 4_LS )_) ._. In_IN line_NN B_NNP ,_, an_DT intermediate_JJ situation_NN is_VBZ
          observed_VBN since_IN high_JJ levels_NNS of_IN RARγ_NNP 2_CD are_VBP seen_VBN at_IN day_NN 3_CD
          which_WDT decrease_VBP by_IN day_NN 5_CD (_( lanes_NNS 3_CD -_: 4_LS )_) ._. In_IN all_DT cases_NNS ,_, low_JJ
          levels_NNS of_IN only_RB the_DT unphosphorylated_JJ RARγ_NNP 2_CD are_VBP detected_VBN by_IN
          days_NNS 7_CD -_: 9_CD (_( lanes_NNS 5_CD -_: 6_CD )_) ._. These_DT results_NNS indicate_VBP that_IN
          proteolytic_JJ degradation_NN of_IN RARγ_NNP 2_CD is_VBZ delayed_VBN in_IN lines_NNS A_DT
          and_CC B_NNP suggesting_VBG that_IN an_DT early_JJ event_NN in_IN the_DT
          differentiation_NN process_NN has_VBZ been_VBN perturbed_VBD ._.
          Comparison_NNP of_IN the_DT growth_NN rate_NN of_IN line_NN A_DT with_IN that_DT of_IN
          wild-type_JJ cells_NNS in_IN the_DT presence_NN of_IN T-RA_NNP ,_, shows_VBZ that_DT line_NN
          A_DT is_VBZ less_RBR sensitive_JJ to_TO the_DT anti-proliferative_JJ effect_NN of_IN
          T-RA_NNP than_IN wild-type_JJ ,_, however_RB growth_NN is_VBZ eventually_RB slowed_VBN
          compared_VBN to_TO undifferentiated_JJ cells_NNS (_( Fig_NNP ._. 4_LS E_NNP )_) ._. Line_NN B_NNP also_RB
          grows_VBZ faster_RBR than_IN wild-type_JJ over_IN the_DT first_JJ 4_CD -_: 6_CD days_NNS ,_, but_CC
          subsequently_RB its_PRP$ growth_NN slows_VBZ and_CC is_VBZ considerably_RB
          retarded_JJ compared_VBN to_TO undifferentiated_JJ cells_NNS (_( Fig_NNP ._. 4_LS E_NNP )_) ._.
          Together_RB these_DT observations_NNS show_VBP that_DT line_NN A_DT is_VBZ poorly_RB
          sensitive_JJ to_TO T-RA-_NNP induced_VBD growth_NN arrest_NN and_CC retains_VBZ an_DT
          essentially_RB undifferentiated_JJ morphology_NN ,_, while_IN growth_NN of_IN
          line_NN B_NNP slows_VBZ after_IN 4_CD -_: 6_CD days_NNS of_IN T-RA_NNP treatment_NN and_CC
          morphological_JJ differentiation_NN is_VBZ retarded_JJ ._.
          We_PRP determined_VBD whether_IN fTAF_NN 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) expression_NN modified_VBN
          T-RA_NNP induced_VBD apoptosis_NNS ._. The_DT proportion_NN of_IN early_JJ apoptotic_JJ
          cells_NNS in_IN lines_NNS A_DT ,_, B_NNP ,_, and_CC wild-type_JJ was_VBD determined_VBN by_IN flow_NN
          cytometry_NN in_IN the_DT presence_NN of_IN propidium_NN iodide_NN and_CC annexin_NN
          V-FITC_NNP [_NN 25_CD ,_, 54_CD ,_, 55_CD ]_NN ._. In_IN wild-type_JJ cells_NNS ,_, the_DT proportion_NN
          of_IN early_JJ apoptotic_JJ cells_NNS increased_VBN from_IN 13_CD %_NN in_IN the_DT
          absence_NN of_IN T-RA_NNP to_TO 26_CD %_NN after_IN 5_CD days_NNS of_IN T-RA_NNP treatment_NN
          (_( Fig_NNP ._. 5_LS )_) ._. In_IN line_NN A_DT ,_, spontaneous_JJ apoptosis_NNS was_VBD lower_JJR than_IN
          wild_JJ type_NN (_( 7_CD %_NN compared_VBN to_TO 13_CD %_NN )_) and_CC only_RB a_DT mild_JJ increase_NN
          (_( 9_CD %_NN )_) was_VBD seen_VBN by_IN day_NN 5_CD (_( Fig_NNP ._. 5_LS )_) ._. In_IN line_NN B_NNP ,_, spontaneous_JJ
          apoptosis_NNS was_VBD also_RB lower_JJR than_IN wild_JJ type_NN (_( 6_CD %_NN compared_VBN to_TO
          13_CD %_NN )_) ,_, while_IN in_IN the_DT presence_NN of_IN T-RA_NNP the_DT proportion_NN rose_VBD
          to_TO 16_CD %_NN (_( Fig_NNP ._. 5_LS )_) ._. Thus_RB ,_, line_NN A_DT is_VBZ resistant_JJ to_TO T-RA_NNP
          induced_VBD apoptosis_NNS ,_, while_IN line_NN B_NNP shows_VBZ reduced_VBN sensitivity_NN
          to_TO T-RA_NNP induced_VBD apoptosis_NNS ._.
          Differentiation_NNP of_IN lines_NNS A_DT and_CC B_NNP was_VBD further_RBR assessed_VBN
          from_IN changes_NNS in_IN cellular_JJ morphology_NN ._. 6_CD -_: 8_CD days_NNS after_IN the_DT
          addition_NN of_IN T-RA_NNP ,_, wild-type_JJ F_NN 9_CD cells_NNS adopt_VBP a_DT typical_JJ
          flattened_VBN primitive_JJ endodermal_NN morphology_NN (_( see_VB upper_JJ
          panel_NN of_IN Fig_NNP ._. 7_CD )_) ._. In_IN contrast_NN ,_, line_NN A_DT cells_NNS retain_VBP an_DT
          essentially_RB undifferentiated_JJ morphology_NN even_RB after_IN 8_CD days_NNS
          of_IN T-RA_NNP treatment_NN (_( centre_NN panel_NN Fig_NNP ._. 7_CD )_) ._. The_DT
          differentiation_NN of_IN line_NN A_DT is_VBZ severely_RB impaired_VBN ,_, as_IN the_DT
          cells_NNS never_RB adopt_VBP a_DT differentiated_JJ morphology_NN even_RB after_IN
          10_CD -_: 12_CD days_NNS of_IN RA-treatment_NNP (_( data_NNS not_RB shown_VBN )_) ._. Similarly_RB ,_,
          line_NN B_NNP cells_NNS appear_VBP essentially_RB undifferentiated_JJ after_IN 6_CD
          days_NNS of_IN T-RA_NNP treatment_NN (_( lower_JJR panel_NN ,_, Fig_NNP ._. 7_CD )_) ._. After_IN 8_CD
          days_NNS ,_, a_DT fraction_NN of_IN the_DT cells_NNS begin_VBP to_TO adopt_VB a_DT primitive_JJ
          endodermal_NN type_NN morphology_NN ,_, although_IN the_DT cells_NNS are_VBP much_RB
          less_RBR flattened_VBN than_IN wild-type_JJ cells_NNS ,_, and_CC the_DT majority_NN of_IN
          the_DT cells_NNS retain_VBP an_DT undifferentiated_JJ morphology_NN (_( Fig_NNP ._. 7_CD )_) ._.
          Only_RB after_IN 10_CD days_NNS of_IN T-RA_NNP treatment_NN did_VBD the_DT majority_NN of_IN
          the_DT cells_NNS adopt_VBP a_DT differentiated_JJ morphology_NN (_( data_NNS not_RB
          shown_VBN )_) ._.
          F_NN 9_CD cell_NN differentiation_NN is_VBZ characterised_JJ by_IN the_DT
          induction_NN of_IN different_JJ marker_NN genes_NNS ._. We_PRP used_VBD reverse_VB
          transcription_NN coupled-_NN PCR_NNP (_( RT-PCR_NNP )_) to_TO compare_VB the_DT
          induction_NN of_IN some_DT of_IN these_DT genes_NNS in_IN lines_NNS A_DT and_CC B_NNP with_IN
          that_DT observed_VBD in_IN wild-type_JJ cells_NNS ._. The_DT RARβ_NNP 2_CD gene_NN is_VBZ a_DT
          marker_NN which_WDT is_VBZ rapidly_RB induced_VBN in_IN wild-type_JJ cells_NNS
          normally_RB ,_, after_IN 12_CD -_: 24_CD hours_NNS [_NN [_NN 49_CD 50_CD 51_CD ]_NN ,_, 56_CD ]_NN ._. In_IN
          agreement_NN with_IN this_DT ,_, the_DT RARβ_NNP 2_CD mRNA_NN is_VBZ fully_RB induced_VBN by_IN
          day_NN 3_CD in_IN wild-type_JJ cells_NNS ._. Expression_NNP persists_VBZ until_IN day_NN 5_CD
          and_CC decreases_NNS only_RB by_IN day_NN 7_CD (_( Fig_NNP ._. 8_CD A_DT ,_, lanes_NNS 2_CD -_: 5_CD ,_, note_NN
          that_IN the_DT small_JJ increase_NN in_IN lane_NN 5_CD in_IN this_DT experiment_NN is_VBZ
          not_RB reproducibly_RB observed_VBD )_) ._. In_IN contrast_NN ,_, in_IN lines_NNS A_DT and_CC
          B_NNP ,_, RARβ_NNP 2_CD expression_NN is_VBZ weak_JJ at_IN day_NN 3_CD ,_, peaks_NNS only_RB at_IN day_NN
          5_CD ,_, and_CC drops_NNS off_IN by_IN day_NN 7_CD (_( lanes_NNS 7_CD -_: 10_CD and_CC 12_CD -_: 15_CD )_) ._. Thus_RB ,_,
          induction_NN of_IN RARβ_NNP 2_CD is_VBZ severely_RB retarded_JJ and_CC transient_JJ in_IN
          lines_NNS A_DT and_CC B_NNP ._. In_IN the_DT same_JJ RNA_NNP samples_NNS ,_, constant_JJ
          expression_NN levels_NNS of_IN HPRT_NNP were_VBD observed_VBN in_IN differentiated_JJ
          and_CC undifferentiated_JJ cells_NNS ._. In_IN contrast_NN to_TO the_DT RARβ_NNP 2_CD
          gene_NN ,_, induction_NN of_IN the_DT collagen_NN IVα_NNP 1_CD and_CC laminin_NN B_NNP 1_CD mRNAs_NNS
          was_VBD almost_RB identical_JJ in_IN the_DT wild-type_JJ and_CC mutant_JJ cells_NNS
          (_( Fig_NNP ._. 8_CD Band_NNP data_NNS not_RB shown_VBN )_) showing_VBG that_IN the_DT delay_NN in_IN
          induction_NN is_VBZ specific_JJ to_TO RARβ_NNP 2_CD ._.
          After_IN 6_CD days_NNS of_IN T-RA_NNP treatment_NN ,_, bt_NN 
          2_CD cAMP_NN was_VBD added_VBN to_TO induce_VB parietal_NN
          endoderm_NN differentiation_NN ._. Addition_NNP of_IN bt_NN 
          2_CD cAMP_NN induced_VBD the_DT rapid_JJ appearance_NN of_IN
          rounded_VBN cells_NNS with_IN typical_JJ parietal_NN endoderm_NN morphology_NN
          for_IN both_DT the_DT wild_JJ type_NN cells_NNS and_CC lines_NNS A_DT and_CC B_NNP (_( Fig_NNP ._. 9_CD )_) ._.
          Thus_RB ,_, while_IN primitive_JJ endoderm_NN differentiation_NN of_IN lines_NNS A_DT
          and_CC B_NNP is_VBZ impaired_VBN ,_, they_PRP readily_RB differentiate_VB into_IN
          parietal_NN endoderm_NN ._.
          In_IN lines_NNS A_DT and_CC B_NNP ,_, we_PRP noticed_VBD after_IN 6_CD -_: 8_CD days_NNS of_IN T-RA_NNP
          treatment_NN the_DT appearance_NN of_IN a_DT novel_NN cell_NN type_NN
          characterised_JJ by_IN elongated_JJ tightly_RB packed_VBN cells_NNS (_( Fig_NNP ._.
          10_CD A_DT )_) ._. The_DT morphology_NN of_IN these_DT cells_NNS was_VBD completely_RB
          different_JJ from_IN those_DT of_IN undifferentiated_JJ or_CC primitive_JJ
          endoderm_NN cells_NNS ._. Although_IN the_DT majority_NN of_IN the_DT cell_NN
          population_NN differentiates_NNS when_WRB bt_NN 
          2_CD cAMP_NN is_VBZ added_VBN to_TO these_DT cultures_NNS ,_, the_DT
          elongated_JJ cells_NNS persisted_VBD even_RB after_IN several_JJ days_NNS of_IN bt_NN 
          2_CD cAMP_NN treatment_NN (_( Fig_NNP ._. 10_CD B_NNP )_) showing_VBG
          that_IN these_DT cells_NNS are_VBP refractory_JJ to_TO the_DT differentiating_VBG
          effect_NN of_IN bt_NN 
          2_CD cAMP_NN ._. Cells_NNP with_IN this_DT atypical_JJ
          morphology_NN were_VBD not_RB observed_VBN when_WRB wild-type_JJ cells_NNS or_CC fTAF_NN
          
          II_NNP 135_CD (_( 805_CD -_: 1083_CD )_) expressing_VBG cells_NNS are_VBP
          differentiated_JJ either_CC with_IN T-RA_NNP or_CC T-RA_NNP and_CC bt_NN 
          2_CD cAMP_NN ._. Therefore_RB ,_, ectopic_JJ expression_NN
          of_IN fTAF_NN 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) has_VBZ induced_VBN a_DT novel_NN
          differentiation_NN pathway_NN leading_VBG to_TO the_DT appearance_NN of_IN
          atypical_JJ elongated_JJ cells_NNS ._.
          Taken_VBN altogether_RB ,_, the_DT above_JJ results_NNS show_VBP that_IN
          primitive_JJ endoderm_NN differentiation_NN of_IN F_NN 9_CD cells_NNS is_VBZ blocked_VBN
          in_IN line_NN A_DT expressing_VBG the_DT highest_JJS level_NN of_IN TAF_NNP 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) and_CC is_VBZ significantly_RB
          retarded_JJ in_IN line_NN B_NNP cells_NNS which_WDT express_VBP lower_JJR levels_NNS of_IN
          TAF_NNP 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) ._. In_IN contrast_NN ,_, all_DT
          three_CD fTAF_NN 
          II_NNP 135_CD (_( 805_CD -_: 1083_CD )_) expressing_VBG cell_NN lines_NNS
          and_CC several_JJ control_NN lines_NNS picked_VBD at_IN the_DT same_JJ time_NN all_DT
          showed_VBD a_DT normal_JJ T-RA_NNP response_NN with_IN respect_NN to_TO growth_VB
          inhibition_NN ,_, differentiated_JJ cell_NN morphology_NN ,_, and_CC targeted_VBD
          depletion_NN of_IN TAF_NNP 
          II_NNP 135_CD and_CC TBP_NNP (_( Fig_NNP ._. 6_CD Band_NNP data_NNS not_RB
          shown_VBN )_) ._.
        
        
          TAF_NNP II_NNP 135_CD and_CC TBP_NNP are_VBP depleted_VBN in_IN extracts_NNS from_IN
          differentiated_JJ C_NNP 2_CD C_NNP 12_CD cells_NNS
          To_TO determine_VB whether_IN the_DT down_NN regulation_NN of_IN TBP_NNP and_CC
          TAF_NNP 
          II_NNP 135_CD is_VBZ specific_JJ to_TO F_NN 9_CD cell_NN
          differentiation_NN we_PRP asked_VBD whether_IN this_DT phenomenon_NN could_MD be_VB
          observed_VBN in_IN an_DT unrelated_JJ cell_NN type_NN ._. C_NNP 2_CD C_NNP 12_CD are_VBP mouse_NN
          skeletal_NN muscle_NN myoblasts_NNS which_WDT differentiate_VB into_IN
          multinucleated_JJ myotubes_NNS [_NN 57_CD ]_NN ._. This_DT differentiation_NN
          process_NN does_VBZ not_RB require_VB the_DT addition_NN of_IN retinoic_JJ acid_NN ,_,
          but_CC takes_VBZ place_NN spontaneously_RB when_WRB cultures_NNS are_VBP grown_VBN to_TO
          high_JJ density_NN and_CC undergo_VBP growth_NN arrest_NN ._.
          In_IN extracts_NNS from_IN differentiating_VBG C_NNP 2_CD C_NNP 12_CD cells_NNS ,_, a_DT
          progressive_JJ decrease_NN in_IN TAF_NNP 
          II_NNP 135_CD and_CC TBP_NNP can_MD be_VB seen_VBN beginning_VBG
          on_IN day_NN 6_CD such_JJ that_IN these_DT proteins_NNS are_VBP strongly_RB depleted_VBN
          from_IN the_DT extracts_NNS by_IN day_NN 11_CD (_( Fig_NNP ._. 11_CD A_DT ,_, lanes_NNS 1_CD -_: 5_CD compare_VB
          with_IN lane_NN 6_CD )_) ._. In_IN contrast_NN ,_, the_DT levels_NNS of_IN TAF_NNP 
          II_NNP 55_CD remain_VB constant_JJ (_( Fig_NNP ._. 11_CD A_DT )_) ._. The_DT
          observed_VBN depletion_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD was_VBD not_RB observed_VBN when_WRB the_DT cells_NNS
          on_IN day_NN 10_CD were_VBD treated_VBN with_IN MG_NNP 132_CD for_IN 12_CD hours_NNS prior_RB to_TO
          extract_VB preparation_NN on_IN day_NN 11_CD (_( Fig_NNP ._. 11_CD B_NNP ,_, lanes_NNS 1_CD -_: 3_LS )_) ._.
          These_DT results_NNS indicate_VBP that_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD are_VBP also_RB targetted_JJ for_IN
          proteolytic_JJ degradation_NN during_IN C_NNP 2_CD C_NNP 12_CD cell_NN
          differentiation_NN ._.
        
      
      
        Discussion_NNP
        
          Post-transcriptional_NNP regulation_NN of_IN TAF_NNP II_NNP 135_CD and_CC
          TBP_NNP in_IN differentiated_JJ F_NN 9_CD cells_NNS
          We_PRP show_VBP here_RB that_WDT targeted_VBD proteolysis_NNS of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD is_VBZ an_DT integral_JJ part_NN of_IN the_DT T-RA_NNP
          response_NN in_IN F_NN 9_CD cells_NNS ._. This_DT process_NN is_VBZ specific_JJ for_IN TBP_NNP
          and_CC TAF_NNP 
          II_NNP 135_CD as_IN it_PRP is_VBZ not_RB observed_VBN with_IN the_DT
          other_JJ TFIID_NNP components_NNS analysed_JJ ,_, and_CC is_VBZ induced_VBN
          concomitantly_RB with_IN that_DT of_IN the_DT RARγ_NNP 2_CD ._. In_IN F_NN 9_CD cells_NNS with_IN
          constitutive_JJ ectopic_JJ expression_NN of_IN TAF_NNP 
          II_NNP 135_CD ,_, targeted_VBN degradation_NN is_VBZ
          delayed_VBN ,_, primitive_JJ endodermal_NN differentiation_NN is_VBZ impaired_VBN
          and_CC a_DT novel_NN differentiation_NN pathway_NN is_VBZ induced_VBN ._. Hence_RB ,_,
          targeted_VBN degradation_NN of_IN TAF_NNP 
          II_NNP 135_CD and_CC TBP_NNP is_VBZ a_DT prerequisite_NN for_IN
          proper_JJ F_NN 9_CD celll_NN differentiation_NN ._.
          TAF_NNP 
          II_NNP 135_CD and_CC TBP_NNP progressively_RB disappear_VBP
          from_IN whole_JJ cell_NN or_CC nuclear_JJ extracts_NNS made_VBN from_IN T-RA_NNP
          differentiated_JJ F_NN 9_CD cells_NNS ._. This_DT depletion_NN does_VBZ not_RB result_VB
          from_IN altered_VBN transcription_NN of_IN these_DT genes_NNS ,_, since_IN no_DT
          significant_JJ changes_NNS in_IN the_DT corresponding_JJ mRNA_NN levels_NNS were_VBD
          observed_VBN during_IN differentiation_NN ._. In_IN lines_NNS A_DT and_CC B_NNP ,_, the_DT
          ectopic_JJ expression_NN of_IN f-_NN TAF_NNP 
          II_NNP 135_CD is_VBZ driven_VBN by_IN a_DT synthetic_JJ
          promoter_NN ,_, yet_RB coordinate_VB depletion_NN of_IN the_DT exogenous_JJ and_CC
          endogenous_JJ TAF_NNP 
          II_NNP 135_CD is_VBZ observed_VBN further_JJ confirming_VBG
          that_IN this_DT is_VBZ indeed_RB a_DT post-transcriptional_JJ event_NN ._.
          In_IN contrast_NN ,_, TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD are_VBP readily_RB detected_VBN in_IN
          extracts_NNS made_VBN from_IN differentiated_JJ cells_NNS treated_VBN with_IN
          MG_NNP 132_CD ,_, ALLN_NNP ,_, and_CC the_DT proteasome-specific_JJ inhibitor_NN
          lactacystin_NN (_( our_PRP$ unpublished_JJ data_NNS )_) showing_VBG that_IN their_PRP$
          disappearance_NN is_VBZ due_JJ to_TO selective_JJ proteolysis_NNS ._. In_IN the_DT
          presence_NN of_IN the_DT inhibitors_NNS ,_, the_DT detected_VBD levels_NNS are_VBP
          significantly_RB lower_JJR than_IN those_DT seen_VBN in_IN equivalent_NN
          extracts_NNS made_VBN from_IN undifferentiated_JJ cells_NNS ._. Addition_NNP of_IN
          the_DT protease_NN inhibitors_NNS only_RB during_IN the_DT extraction_NN
          procedure_NN is_VBZ another_DT way_NN to_TO measure_NN of_IN the_DT intracellular_NN
          level_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD ._. In_IN these_DT extracts_NNS also_RB ,_, the_DT
          levels_NNS of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD are_VBP significantly_RB reduced_VBN in_IN
          differentiated_JJ cells_NNS compared_VBN with_IN undifferentiated_JJ
          cells_NNS ._. Therefore_RB ,_, the_DT intracellular_NN levels_NNS of_IN TBP_NNP and_CC TAF_NNP
          
          II_NNP 135_CD and_CC consequently_RB TFIID_NNP are_VBP
          reduced_VBN in_IN differentiated_JJ cells_NNS through_IN selective_JJ
          proteolysis_NNS ._.
          Targeted_NNP degradation_NN of_IN TAF_NNP 
          II_NNP 135_CD does_VBZ not_RB require_VB amino_JJ acids_NNS
          1_CD -_: 372_CD since_IN deletion_NN mutant_JJ (_( 372_CD -_: 1083_CD )_) is_VBZ targeted_VBN along_IN
          with_IN the_DT endogenous_JJ protein_NN in_IN lines_NNS A_DT and_CC B_NNP ._. In_IN
          contrast_NN ,_, mutant_JJ (_( 805_CD -_: 1083_CD )_) is_VBZ not_RB degraded_JJ during_IN
          differentiation_NN indicating_VBG that_IN the_DT sequences_NNS required_VBN
          for_IN targeting_VBG are_VBP located_VBN between_IN amino_JJ acids_NNS 372_CD -_: 805_CD ._.
          Many_JJ of_IN proteins_NNS which_WDT are_VBP targeted_VBN for_IN proteolytic_JJ
          degradation_NN contain_VB signal_NN sequences_NNS such_JJ as_IN PEST_NNP or_CC
          cyclin_NN destruction_NN boxes_NNS which_WDT mediate_VB their_PRP$ proteolysis_NNS ,_,
          however_RB no_DT recognised_JJ destabilising_VBG motifs_NNS are_VBP present_JJ in_IN
          TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD and_CC indeed_RB these_DT proteins_NNS are_VBP
          stable_JJ in_IN non-differentiated_JJ F_NN 9_CD cells_NNS and_CC in_IN many_JJ other_JJ
          cell_NN types_NNS ._. It_PRP will_MD therefore_RB be_VB interesting_JJ to_TO identify_VB
          the_DT sequences_NNS are_VBP required_VBN for_IN degradation_NN of_IN TBP_NNP and_CC TAF_NNP
          
          II_NNP 135_CD in_IN differentiating_VBG F_NN 9_CD cells_NNS ._. In_IN
          this_DT respect_NN we_PRP note_VBP that_IN we_PRP have_VBP not_RB been_VBN able_JJ to_TO
          recover_VB F_NN 9_CD cell_NN lines_NNS significantly_RB overexpressing_VBG TBP_NNP
          suggesting_VBG that_IN TBP_NNP overexpression_NN is_VBZ toxic_JJ ._.
          In_IN F_NN 9_CD cells_NNS ,_, RARγ_NNP 2_CD plays_VBZ a_DT key_JJ role_NN in_IN primitive_JJ
          endoderm_NN differentiation_NN [_NN [_NN 58_CD 59_CD ]_NN ]_NN ._. 48_CD hours_NNS after_IN
          addition_NN of_IN T-RA_NNP degradation_NN of_IN this_DT protein_NN begins_VBZ such_JJ
          that_IN by_IN 3_CD -_: 4_CD days_NNS most_JJS of_IN the_DT protein_NN is_VBZ depleted_VBN [_NN 42_CD ]_NN ._.
          The_DT onset_NN of_IN RARγ_NNP 2_CD degradation_NN coincides_VBZ with_IN that_DT of_IN TBP_NNP
          and_CC TAF_NNP 
          II_NNP 135_CD suggesting_VBG that_IN these_DT events_NNS
          are_VBP causaly_RB related_VBN ._. This_DT idea_NN is_VBZ supported_VBN by_IN the_DT fact_NN
          that_IN in_IN line_NN A_DT degradation_NN of_IN TBP_NNP ,_, TAF_NNP 
          II_NNP 135_CD ,_, and_CC RARγ_NNP 2_CD are_VBP all_DT delayed_VBN to_TO
          similar_JJ extents_NNS ._. A_DT lesser_JJR delay_NN in_IN degradation_NN of_IN RARγ_NNP 2_CD
          in_IN line_NN B_NNP was_VBD also_RB observed_VBN ._. If_IN the_DT corresponding_JJ delay_NN
          in_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD degradation_NN in_IN line_NN B_NNP was_VBD less_JJR
          than_IN two_CD days_NNS ,_, it_PRP would_MD be_VB missed_VBN since_IN we_PRP prepared_VBD
          extracts_NNS at_IN two_CD day_NN intervals_NNS ._. All_DT of_IN these_DT observations_NNS
          are_VBP consistent_JJ with_IN the_DT idea_NN that_IN upon_IN exposure_NN to_TO T-RA_NNP
          there_EX is_VBZ an_DT early_JJ transcriptional_NN response_NN in_IN which_WDT a_DT
          RARγ_NNP 2_CD /_NN RXR_NNP heterodimer_NN activates_NNS genes_NNS required_VBN for_IN
          differentiation_NN ._. As_IN a_DT consequence_NN ,_, the_DT RARγ_NNP 2_CD ,_, and_CC the_DT TAF_NNP
          
          II_NNP 135_CD and_CC TBP_NNP components_NNS of_IN the_DT basal_NN
          transcription_NN machinery_NN are_VBP down-regulated_JJ through_IN
          proteolytic_JJ degradation_NN ._. It_PRP has_VBZ been_VBN suggested_VBN that_DT
          degradation_NN of_IN the_DT RARγ_NNP 2_CD or_CC the_DT ER_NNP is_VBZ a_DT means_NN of_IN
          regulating_VBG the_DT cellular_JJ response_NN to_TO these_DT ligands_NNS both_DT in_IN
          terms_NNS of_IN magnitude_NN and_CC time_NN [_NN 42_CD ,_, 44_CD ]_NN ._. The_DT coordinate_VB
          degradation_NN of_IN RARγ_NNP 2_CD ,_, TBP_NNP ,_, and_CC TAF_NNP 
          II_NNP 135_CD in_IN response_NN to_TO T-RA_NNP indicates_VBZ
          that_IN the_DT cellular_JJ T-RA_NNP response_NN is_VBZ not_RB only_RB regulated_VBN
          through_IN degradation_NN of_IN the_DT activator_NN ,_, but_CC also_RB through_IN
          degradation_NN of_IN components_NNS of_IN the_DT basal_NN transcription_NN
          machinery_NN ._.
          The_DT differentiation_NN of_IN C_NNP 2_CD C_NNP 12_CD myoblasts_NNS into_IN myotubes_NNS
          does_VBZ not_RB require_VB T-RA_NNP ,_, but_CC is_VBZ induced_VBN by_IN growth_NN
          inhibition_NN and_CC serum_NN starvation_NN ._. Despite_IN the_DT important_JJ
          differences_NNS between_IN these_DT cells_NNS and_CC F_NN 9_CD cells_NNS ,_, targeted_VBN
          degradation_NN of_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD is_VBZ also_RB observed_VBN when_WRB C_NNP 2_CD C_NNP 12_CD
          cells_NNS differentiate_VB ._. Hence_RB ,_, targeted_VBN degradation_NN can_MD be_VB
          induced_VBN by_IN stimuli_NNS other_JJ than_IN T-RA_NNP ._. Our_PRP$ report_NN is_VBZ the_DT
          first_JJ showing_NN that_DT basal_NN transcription_NN factors_NNS can_MD be_VB
          regulated_VBN in_IN this_DT way_NN in_IN response_NN to_TO different_JJ
          physiological_JJ stimuli_NNS ._.
          As_IN described_VBD in_IN the_DT Introduction_NNP ,_, recent_JJ studies_NNS
          indicate_VBP that_IN the_DT activation_NN process_NN is_VBZ linked_VBN to_TO
          targeted_VBN proteolysis_NNS of_IN transcriptional_NN activators_NNS ._. In_IN
          the_DT case_NN of_IN the_DT RARγ_NNP 2_CD ,_, degradation_NN requires_VBZ a_DT
          constitutive_JJ phosphorylation_NN of_IN the_DT AF-_NNP 1_CD domain_NN ,_,
          heterodimerisation_NN with_IN RXR_NNP ,_, and_CC the_DT presence_NN of_IN ligand_NN
          indicating_VBG that_IN the_DT receptor_NN has_VBZ to_TO be_VB transcriptionally_RB
          active_JJ to_TO be_VB degraded_JJ [_NN 42_CD ]_NN ._. Under_IN these_DT conditions_NNS the_DT
          receptor_NN is_VBZ ubiquitinated_JJ and_CC degraded_JJ ._. While_IN we_PRP have_VBP not_RB
          been_VBN able_JJ to_TO directly_RB detect_VB ubiquitination_NN of_IN TBP_NNP or_CC TAF_NNP
          
          II_NNP 135_CD in_IN extracts_NNS where_WRB
          ubiquitination_NN of_IN RARγ_NNP 2_CD can_MD be_VB detected_VBN (_( our_PRP$ unpublished_JJ
          data_NNS )_) ,_, at_IN early_JJ times_NNS we_PRP do_VBP observe_VBP a_DT significant_JJ shift_NN
          in_IN the_DT electrophoretic_JJ mobility_NN of_IN TAF_NNP 
          II_NNP 135_CD which_WDT may_MD correspond_VB to_TO a_DT
          polyubiquitinated_JJ intermediate_JJ While_IN the_DT molecular_JJ events_NNS
          involved_VBN in_IN degradation_NN of_IN transcription_NN factors_NNS are_VBP in_IN
          general_JJ poorly_RB understood_VBN ,_, it_PRP is_VBZ noteworthy_JJ that_IN both_DT NRs_NNP
          and_CC TBP_NNP have_VBP been_VBN reported_VBN to_TO interact_NN with_IN the_DT
          proteasome_NN component_NN SUG_NNP 1_CD [_NN [_NN 60_CD 61_CD ]_NN ]_NN which_WDT may_MD act_VB to_TO
          target_VB these_DT proteins_NNS for_IN degradation_NN ._. In_IN addition_NN ,_, other_JJ
          components_NNS of_IN the_DT proteasome_NN /_NN ubiquitin_NN degradation_NN
          pathway_NN have_VBP also_RB been_VBN shown_VBN to_TO interact_NN with_IN either_DT
          nuclear_JJ receptors_NNS or_CC components_NNS of_IN the_DT preinitiation_NN
          complex_JJ (_( for_IN review_NN see_VB [_NN 38_CD ]_NN )_) ._. Further_RB experiments_NNS will_MD
          be_VB required_VBN to_TO determine_VB whether_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD are_VBP modified_VBN directly_RB to_TO allow_VB
          targeting_VBG ,_, or_CC whether_IN they_PRP are_VBP targeted_VBN indirectly_RB
          through_IN the_DT formation_NN of_IN transcriptionally_RB active_JJ
          complexes_NNS with_IN the_DT RARγ_NNP 2_CD which_WDT ,_, as_IN it_PRP is_VBZ itself_PRP degraded_JJ ,_,
          acts_VBZ to_TO recruit_VB the_DT degradation_NN machinery_NN ._.
          A_DT decreased_VBN level_NN of_IN TBP_NNP in_IN differentiated_JJ F_NN 9_CD cells_NNS
          has_VBZ previously_RB been_VBN noted_VBN [_NN 62_CD ,_, 63_CD ]_NN ._. These_DT studies_NNS did_VBD
          not_RB address_VB the_DT mechanism_NN underlying_VBG its_PRP$ down-regulation_JJ ,_,
          but_CC they_PRP revealed_VBD a_DT down-regulation_JJ of_IN the_DT pol_NN III_NNP TAF_NNP
          BRF_NNP and_CC the_DT pol_NN I_PRP TAF_NNP 
          I_PRP 48_CD and_CC TAF_NNP 
          I_PRP 95_CD proteins_NNS and_CC diminished_VBN
          transcription_NN by_IN the_DT corresponding_JJ polymerases_NNS in_IN T-RA_NNP
          differentiated_JJ F_NN 9_CD cells_NNS ._. In_IN the_DT light_NN of_IN the_DT present_JJ
          study_NN ,_, it_PRP is_VBZ possible_JJ that_IN the_DT BRF_NNP ,_, TAF_NNP 
          I_PRP 48_CD ,_, and_CC TAF_NNP 
          I_PRP 95_CD proteins_NNS are_VBP also_RB
          post-transcriptionally_JJ down-regulated_JJ by_IN targeted_VBN
          proteolysis_NNS in_IN the_DT same_JJ way_NN as_IN TBP_NNP and_CC TAF_NNP 
          II_NNP 135_CD ._. This_DT pathway_NN may_MD therefore_RB be_VB
          used_VBN to_TO more_RBR generally_RB regulate_VB the_DT activity_NN of_IN all_DT three_CD
          RNA_NNP polymerases_NNS during_IN differentiation_NN ._.
        
        
          TAF_NNP II_NNP 135_CD plays_VBZ a_DT key_JJ role_NN in_IN F_NN 9_CD cell_NN growth_NN and_CC
          differentiation_NN
          We_PRP show_VBP here_RB that_IN T-RA-_NNP induced_VBD primitive_JJ endoderm_NN
          differentiation_NN is_VBZ impaired_VBN in_IN cell_NN lines_NNS constitutively_RB
          expressing_VBG ectopic_JJ TAF_NNP 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) as_IN judged_VBN from_IN ,_,
          retarded_JJ targeted_VBN degradation_NN of_IN RARγ_NNP 2_CD ,_, cell_NN morphology_NN ,_,
          growth_NN inhibition_NN ,_, apoptotic_JJ response_NN ,_, and_CC induction_NN of_IN
          the_DT RARβ_NNP 2_CD marker_NN gene_NN ._. The_DT effects_NNS are_VBP most_RBS pronounced_VBN in_IN
          line_NN A_DT cells_NNS which_WDT express_VBP the_DT highest_JJS level_NN of_IN ectopic_JJ
          TAF_NNP 
          II_NNP 135_CD and_CC do_VBP not_RB show_VB a_DT
          differentiated_JJ cell_NN morphology_NN even_RB upon_IN prolonged_JJ
          exposure_NN to_TO T-RA_NNP ._. An_DT intermediate_JJ ,_, but_CC significant_JJ ,_,
          effect_NN is_VBZ seen_VBN using_VBG all_DT criteria_NNS tested_VBN in_IN line_NN B_NNP cells_NNS ,_,
          where_WRB fTAF_NN 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) expression_NN is_VBZ lower_JJR ._.
          In_IN contrast_NN ,_, cells_NNS expressing_VBG fTAF_NN 
          II_NNP 135_CD (_( 805_CD -_: 1083_CD )_) differentiate_VB
          normally_RB ._.
          The_DT RARβ_NNP 2_CD gene_NN is_VBZ normally_RB fully_RB induced_VBN by_IN 12_CD -_: 24_CD
          hours_NNS [_NN 56_CD ]_NN and_CC elevated_VBD expression_NN persists_VBZ up_RB until_IN day_NN
          5_CD ._. In_IN lines_NNS A_DT and_CC B_NNP ,_, induction_NN was_VBD seen_VBN only_RB after_IN 5_CD days_NNS
          and_CC this_DT induction_NN was_VBD transient_JJ compared_VBN to_TO wild-type_JJ
          cells_NNS ._. As_IN the_DT RARβ_NNP 2_CD gene_NN is_VBZ important_JJ for_IN T-RA-_NNP induced_VBD
          growth_NN arrest_NN [_NN 64_CD ]_NN ,_, its_PRP$ delayed_VBN induction_NN in_IN lines_NNS A_DT and_CC
          B_NNP may_MD in_IN part_VB explain_VBP the_DT phenotype_NN of_IN these_DT cells_NNS ._.
          Nevertheless_RB ,_, the_DT collagen_NN IVα_NNP 1_CD and_CC laminin_NN B_NNP 1_CD genes_NNS (_( as_RB
          well_RB as_IN several_JJ other_JJ known_VBN marker_NN genes_NNS ,_, our_PRP$ unpublished_JJ
          data_NNS )_) ,_, are_VBP induced_VBN normally_RB in_IN lines_NNS A_DT and_CC B_NNP by_IN day_NN 3_CD -_: 5_CD
          even_RB when_WRB no_DT obvious_JJ morphological_JJ differentiation_NN is_VBZ
          observed_VBN ._. This_DT differential_NN induction_NN of_IN the_DT RARβ_NNP 2_CD versus_CC
          other_JJ marker_NN genes_NNS has_VBZ not_RB been_VBN previously_RB noted_VBN in_IN the_DT
          various_JJ RAR_NNP and_CC RXR_NNP knock_VB out_IN cell_NN lines_NNS analysed_JJ ._. The_DT
          phenotype_NN generated_VBN by_IN ectopic_JJ TAF_NNP 
          II_NNP 135_CD expression_NN is_VBZ therefore_RB
          distinct_JJ from_IN that_DT seen_VBN in_IN these_DT knock_NN out_IN cell_NN lines_NNS ._.
          Most_JJS of_IN the_DT currently_RB identified_VBN marker_NN genes_NNS are_VBP not_RB
          appropriate_JJ for_IN the_DT analysis_NN of_IN the_DT phenotype_NN of_IN these_DT
          lines_NNS ._. A_DT detailed_VBN understanding_NN of_IN how_WRB ectopically_RB
          expressed_VBD TAF_NNP 
          II_NNP 135_CD blocks_NNS primitive_JJ endoderm_NN
          differentiation_NN will_MD require_VB the_DT identification_NN of_IN novel_NN
          marker_NN genes_NNS whose_WP$ expression_NN is_VBZ significantly_RB altered_VBN in_IN
          lines_NNS A_DT and_CC B_NNP and_CC which_WDT may_MD be_VB directly_RB regulated_VBN by_IN TAF_NNP 
          II_NNP 135_CD ._.
          Despite_IN the_DT fact_NN that_IN primitive_JJ endoderm_NN
          differentiation_NN of_IN these_DT lines_NNS is_VBZ perturbed_VBD ,_, they_PRP
          differentiate_VB normally_RB into_IN parietal_NN endoderm_NN ._. This_DT shows_VBZ
          that_IN ,_, in_IN contrast_NN to_TO what_WP has_VBZ previously_RB been_VBN assumed_VBN ,_,
          differentiation_NN into_IN parietal_NN endoderm_NN does_VBZ not_RB require_VB
          the_DT cells_NNS to_TO first_JJ be_VB fully_RB differentiated_JJ into_IN primitive_JJ
          endoderm_NN since_IN line_NN A_DT cells_NNS go_VBP from_IN an_DT essentially_RB
          undifferentiated_JJ morphology_NN to_TO a_DT parietal_NN morphology_NN ._.
          However_RB ,_, even_RB line_NN A_DT is_VBZ not_RB totally_RB refractory_JJ to_TO T-RA_NNP ,_,
          since_IN several_JJ marker_NN genes_NNS are_VBP induced_VBN and_CC they_PRP have_VBP
          become_VBN bt_NN 
          2_CD cAMP_NN responsive_JJ ._. Again_RB ,_, the_DT
          phenotype_NN of_IN these_DT cells_NNS is_VBZ not_RB the_DT same_JJ as_IN that_DT of_IN the_DT
          RXRα_NNP -_: /_NN -_: RARγ_NNP -_: /_NN -_: cells_NNS where_WRB none_NN of_IN these_DT events_NNS take_VBP
          place_NN ._.
          Our_PRP$ results_NNS rather_RB indicate_VBP that_IN ectopic_JJ TAF_NNP 
          II_NNP 135_CD expression_NN acts_NNS at_IN an_DT early_JJ
          stage_NN to_TO impair_VB primitive_JJ endoderm_NN differentiation_NN ,_, but_CC
          does_VBZ not_RB prevent_VB the_DT T-RA-_NNP induced_VBD changes_NNS which_WDT render_VB
          the_DT cells_NNS bt_NN 
          2_CD cAMP_NN responsive_JJ ._. The_DT initial_NN
          elevated_VBD TAF_NNP 
          II_NNP 135_CD expression_NN in_IN lines_NNS A_DT and_CC B_NNP
          impairs_NNS both_DT the_DT T-RA_NNP transcriptional_NN response_NN and_CC its_PRP$
          associated_VBN degradation_NN of_IN RARγ_NNP 2_CD ,_, TBP_NNP ,_, and_CC TAF_NNP 
          II_NNP 135_CD prolonging_VBG the_DT period_NN of_IN
          elevated_JJ expression_NN of_IN these_DT proteins_NNS resulting_VBG in_IN a_DT
          subsequent_JJ block_NN of_IN primitive_JJ endoderm_NN differentiation_NN ._.
          It_PRP has_VBZ previously_RB been_VBN shown_VBN that_DT phosphorylation_NN of_IN the_DT
          RARγ_NNP 2_CD AF-_NNP 1_CD is_VBZ indispensable_JJ for_IN primitive_JJ endoderm_NN
          differentiation_NN [_NN 59_CD ]_NN ._. When_WRB F_NN 9_CD cells_NNS expressing_VBG the_DT RARγ_NNP 2_CD
          in_IN which_WDT the_DT phosphorylation_NN site_NN has_VBZ been_VBN mutated_VBN are_VBP
          treated_VBN with_IN T-RA_NNP ,_, no_DT degradation_NN of_IN this_DT protein_NN is_VBZ
          observed_VBN ._. There_EX is_VBZ therefore_RB an_DT intimate_JJ relationship_NN
          between_IN differentiation_NN and_CC RARγ_NNP 2_CD degradation_NN suggesting_VBG
          that_IN proper_JJ RARγ_NNP 2_CD degradation_NN is_VBZ essential_JJ for_IN
          differentiation_NN [_NN 42_CD ]_NN ._. This_DT idea_NN is_VBZ supported_VBN by_IN our_PRP$
          present_JJ results_NNS since_IN we_PRP show_VBP that_IN TAF_NNP 
          II_NNP 135_CD overexpression_NN impairs_NNS both_DT
          RARγ_NNP 2_CD degradation_NN and_CC primitive_JJ endoderm_NN differentiation_NN ._.
          It_PRP is_VBZ therefore_RB probable_JJ that_IN the_DT increased_VBN stability_NN of_IN
          the_DT RARγ_NNP 2_CD in_IN lines_NNS A_DT and_CC B_NNP is_VBZ the_DT major_JJ cause_NN of_IN their_PRP$
          impaired_VBN primitive_JJ endoderm_NN differentiation_NN ._. It_PRP is_VBZ
          interesting_JJ to_TO note_VB that_IN the_DT TAF_NNP 
          II_NNP 135_CD (_( 805_CD -_: 1083_CD )_) deletion_NN mutant_JJ is_VBZ
          not_RB degraded_JJ in_IN response_NN to_TO T-RA_NNP and_CC its_PRP$ expression_NN does_VBZ
          not_RB interfere_VB with_IN differentiation_NN ._. This_DT suggests_VBZ that_IN
          TAF_NNP 
          II_NNP 135_CD is_VBZ only_RB targeted_VBN for_IN
          degradation_NN if_IN it_PRP contributes_VBZ functionally_RB to_TO the_DT T-RA_NNP
          response_NN ._.
          The_DT severity_NN of_IN the_DT phenotype_NN observed_VBD in_IN lines_NNS A_DT and_CC
          B_NNP correlates_NNS with_IN the_DT expression_NN level_NN of_IN the_DT exogenous_JJ f_SYM
          TAF_NNP 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) protein_NN ,_, a_DT version_NN of_IN
          TAF_NNP 
          II_NNP 135_CD in_IN which_WDT the_DT N-_NNP terminal_NN
          proline-alanine_JJ rich_JJ region_NN has_VBZ been_VBN deleted_VBN ._. The_DT deleted_VBN
          region_NN is_VBZ not_RB conserved_JJ in_IN hTAF_NN 
          II_NNP 105_CD and_CC dTAF_NN 
          II_NNP 110_CD ,_, is_VBZ not_RB involved_VBN in_IN
          interactions_NNS with_IN other_JJ TAF_NNP 
          II_NNP s_VBZ ,_, SP_NNP 1_CD ,_, or_CC CREB_NNP [_NN 26_CD ,_, 27_CD ,_, 33_CD ]_NN ,_, and_CC
          has_VBZ no_DT known_VBN function_NN ._. In_IN agreement_NN with_IN this_DT ,_, the_DT fTAF_NN 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) [_NN and_CC the_DT fTAF_NN 
          II_NNP 135_CD (_( 805_CD -_: 1083_CD )_) ]_NN protein_NN can_MD be_VB
          coprecipitated_JJ with_IN the_DT endogenous_JJ TFIID_NNP of_IN lines_NNS A_DT and_CC B_NNP
          (_( our_PRP$ unpublished_JJ data_NNS )_) ._. It_PRP is_VBZ likely_JJ therefore_RB that_IN the_DT
          phenotype_NN of_IN lines_NNS A_DT and_CC B_NNP results_NNS from_IN the_DT TAF_NNP 
          II_NNP 135_CD overexpression_NN 
          per_IN se_FW ,_, although_IN we_PRP cannot_NN exclude_VBP
          the_DT possibility_NN that_IN the_DT effects_NNS are_VBP not_RB due_JJ only_RB to_TO the_DT
          elevated_VBD expression_NN levels_NNS ,_, but_CC that_IN they_PRP may_MD
          additionally_RB reflect_VB a_DT dominant_JJ negative_JJ property_NN of_IN this_DT
          mutant_JJ ._. Investigation_NNP of_IN this_DT has_VBZ been_VBN hampered_VBN by_IN the_DT
          fact_NN that_IN we_PRP have_VBP not_RB been_VBN able_JJ to_TO isolate_VB F_NN 9_CD cell_NN lines_NNS
          stabley_NN expressing_VBG full_JJ length_NN TAF_NNP 
          II_NNP 135_CD ._.
          Treatment_NNP of_IN lines_NNS A_DT and_CC B_NNP with_IN T-RA_NNP induces_VBZ a_DT
          fraction_NN of_IN the_DT cells_NNS to_TO adopt_VB an_DT atypical_JJ elongated_JJ cell_NN
          morphology_NN ,_, which_WDT to_TO our_PRP$ knowledge_NN has_VBZ not_RB been_VBN
          previously_RB seen_VBN upon_IN differentiation_NN of_IN F_NN 9_CD cells_NNS ._. Unlike_IN
          the_DT other_JJ cells_NNS in_IN the_DT population_NN ,_, these_DT cells_NNS do_VBP not_RB
          differentiate_VB into_IN parietal_NN endoderm_NN showing_VBG that_IN they_PRP
          are_VBP refractory_JJ to_TO bt_NN 
          2_CD cAMP_NN ._. These_DT observations_NNS suggest_VBP
          that_IN ectopic_JJ TAF_NNP 
          II_NNP 135_CD expression_NN promotes_VBZ T-RA_NNP
          induction_NN of_IN genes_NNS which_WDT are_VBP normally_RB not_RB activated_VBN in_IN F_NN 9_CD
          cells_NNS leading_VBG to_TO a_DT novel_NN differentiation_NN pathway_NN ._. It_PRP is_VBZ
          also_RB possible_JJ that_IN TAF_NNP 
          II_NNP 135_CD expression_NN modulates_NNS the_DT
          activity_NN of_IN transcription_NN factors_NNS in_IN addition_NN to_TO the_DT RARs_NNP
          leading_VBG to_TO the_DT appearance_NN of_IN this_DT novel_NN cell_NN type_NN ._.
        
      
      
        Conclusions_NNP
        We_PRP report_VBP for_IN the_DT first_JJ time_NN that_IN components_NNS of_IN the_DT
        basal_NN transcription_NN machinery_NN are_VBP subject_JJ to_TO regulation_NN by_IN
        targeted_VBN proteolysis_NNS in_IN response_NN to_TO a_DT physiological_JJ
        stimulus_NN ._. Our_PRP$ results_NNS point_VBP to_TO a_DT critical_JJ role_NN of_IN TAF_NNP 
        II_NNP 135_CD in_IN F_NN 9_CD cell_NN physiology_NN ._. It_PRP is_VBZ
        downregulated_JJ during_IN F_NN 9_CD cell_NN differentiation_NN and_CC expression_NN
        of_IN TAF_NNP 
        II_NNP 135_CD at_IN elevated_VBD levels_NNS promotes_VBZ cell_NN
        growth_NN ,_, impairs_NNS the_DT normal_JJ T-RA_NNP response_NN ,_, and_CC induces_VBZ a_DT
        novel_NN differentiation_NN pathway_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          F_NN 9_CD and_CC C_NNP 2_CD C_NNP 12_CD cell_NN culture_NN and_CC
          differentiation_NN
          Wild-type_NNP and_CC mutant_JJ F_NN 9_CD cells_NNS were_VBD grown_VBN as_IN described_VBN
          [_NN 25_CD ,_, 49_CD ]_NN ._. Differentiation_NNP was_VBD induced_VBN by_IN addition_NN of_IN 1_CD ._. 0_CD
          μM_NN all-trans_JJ retinoic_JJ acid_NN (_( T-RA_NNP )_) with_IN or_CC without_IN 250_CD μM_NN
          di-butaryl_JJ bt_NN 
          2_CD cAMP_NN ._. In_IN most_JJS experiments_NNS an_DT
          appropriate_JJ number_NN of_IN 10_CD cm_NN plates_NNS were_VBD seeded_VBN with_IN 10_CD
          5_CD cells_NNS and_CC after_IN 24_CD hours_NNS (_( day_NN 0_CD )_) T-RA_NNP was_VBD added_VBN and_CC
          protein_NN or_CC RNA_NNP extracts_NNS were_VBD made_VBN from_IN one_CD plate_NN of_IN cells_NNS
          on_IN each_DT of_IN the_DT indicated_VBN days_NNS ._. Stably_NNP transformed_VBD cell_NN
          lines_NNS were_VBD isolated_VBN by_IN electroporating_VBG plasmid_NN pXJ-fTAF_JJ 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) along_IN with_IN the_DT
          puromycin_NN resistance_NN gene_NN under_IN the_DT control_NN of_IN the_DT SV_NNP 40_CD
          promoter_NN ._. Puromycin_NNP resistant_JJ cell_NN clones_NNS were_VBD selected_VBN
          in_IN the_DT presence_NN of_IN 1_CD μg_NN /_NN ml_NN of_IN puromycin_NN ,_, amplified_VBN ,_, and_CC
          the_DT presence_NN of_IN exogenous_JJ fTAF_NN 
          II_NNP 135_CD (_( 372_CD -_: 1083_CD )_) was_VBD detected_VBN by_IN
          immunoblotting_VBG and_CC immunofluoresence_NN (_( data_NNS not_RB shown_VBN )_) ._.
          Aliquots_NNP of_IN each_DT clone_NN were_VBD frozen_VBN after_IN the_DT minimum_JJ
          number_NN of_IN passages_NNS and_CC three_CD independent_JJ differentiation_NN
          experiments_NNS giving_VBG analogous_JJ results_NNS were_VBD started_VBN from_IN
          the_DT frozen_VBN stocks_NNS ._. For_IN cell_NN growth_NN rates_NNS ,_, 3_CD cm_NN plates_NNS
          were_VBD seeded_VBN with_IN 10_CD 3_CD cells_NNS and_CC after_IN 4_CD -_: 10_CD days_NNS cells_NNS were_VBD
          counted_VBN with_IN a_DT particle_NN counter_NN (_( Coulter_NNP Z_NNP 2_LS )_) ._. C_NNP 2_CD C_NNP 12_CD cells_NNS
          were_VBD maintained_VBN undifferentiated_JJ by_IN growth_NN at_IN low_JJ
          density_NN ._. C_NNP 2_CD C_NNP 12_CD cells_NNS were_VBD differentiated_JJ by_IN plating_VBG at_IN
          high_JJ density_NN and_CC growth_NN in_IN 0_CD ._. 1_CD %_NN serum_NN for_IN the_DT number_NN of_IN
          days_NNS indicated_VBD on_IN the_DT figures_NNS ._. Morphological_NNP
          differentiation_NN was_VBD clearly_RB seen_VBN by_IN light_JJ microscopy_NN ._.
        
        
          Extract_NNP preparation_NN and_CC immunoblotting_VBG
          Protein_NNP extracts_NNS from_IN cells_NNS were_VBD made_VBN essentially_RB as_RB
          previously_RB described_VBD [_NN 4_CD ,_, 65_CD ]_NN ._. Briefly_NNP ,_, cells_NNS were_VBD washed_VBN
          and_CC harvested_VBN with_IN ice_NN cold_JJ phosphate_NN buffered_JJ saline_NN ._.
          Cells_NNP were_VBD then_RB resuspended_JJ in_IN buffer_NN A_DT (_( 50_CD mM_NN Tris-_NNP HCl_NNP
          pH_NN 7_CD ._. 5_CD ,_, 20_CD %_NN glycerol_NN ,_, 1_CD mM_NN Dithiothreitol_NNP ,_, 0_CD ._. 2_CD %_NN Nonidet_NNP
          P-_NNP 40_CD )_) with_IN 0_CD ._. 5_CD M_NNP KCl_NNP and_CC subjected_VBN to_TO two_CD rounds_NNS of_IN
          freeze-thaw_JJ followed_VBN by_IN a_DT 30_CD min_NN incubation_NN on_IN ice_NN ._. The_DT
          cell_NN debris_NN was_VBD then_RB removed_VBN by_IN centrifugation_NN and_CC the_DT
          soluble_JJ protein_NN fraction_NN was_VBD frozen_VBN in_IN liquid_JJ nitrogen_NN
          and_CC stored_VBD at_IN -_: 80_CD °_NN C_NNP ._. Nuclear_JJ extracts_NNS were_VBD prepared_VBN by_IN
          first_JJ lysing_VBG the_DT cells_NNS for_IN 10_CD minutes_NNS in_IN 1_CD ml_NN of_IN isotonic_JJ
          buffer_NN (_( 50_CD mM_NN KCl_NNP ,_, 50_CD mM_NN Tris-_NNP HCl_NNP ,_, pH_NN 7_CD ._. 9_CD ,_, 0_CD ._. 2_CD %_NN NP_NNP 40_CD ,_, 0_CD ._. 5_CD
          mM_NN EDTA_NNP and_CC 1_CD ._. 5_CD mM_NN MgCl_NNP 2_LS )_) ._. The_DT nuclei_NN were_VBD then_RB recovered_VBN
          by_IN centrifugation_NN at_IN 2000_CD rpm_NN for_IN 5_CD minutes_NNS and_CC the_DT
          supernatant_NN containing_VBG the_DT cytoplasmic_JJ proteins_NNS was_VBD
          discarded_VBN ._. Nuclear_JJ protein_NN was_VBD then_RB extracted_VBN from_IN the_DT
          purified_JJ nuclei_NN with_IN buffer_NN A_DT containing_VBG 1_CD ._. 0_CD M_NNP KCl_NNP ._.
          Protein_NNP concentrations_NNS were_VBD determined_VBN by_IN the_DT method_NN of_IN
          Bradford_NNP using_VBG a_DT Biorad_NNP protein_NN assay_NN kit_NN ._. Equal_NNP amounts_NNS
          of_IN protein_NN ,_, normally_RB 10_CD μg_NN unless_IN otherwise_RB stated_VBN ,_, were_VBD
          then_RB subjected_VBN to_TO SDS_NNP PAGE_NNP and_CC immunoblotting_VBG ._. TBP_NNP was_VBD
          detected_VBN using_VBG monoclonal_NN antibodies_NNS 3_CD G_NNP 3_CD and_CC 2_CD C_NNP 1_CD [_NN [_NN 66_CD
          67_CD 68_CD ]_NN ]_NN ._. TAF_NNP 
          II_NNP 135_CD was_VBD detected_VBN using_VBG monoclonal_NN
          antibody_NN 20_CD TA_NNP [_NN 5_CD ]_NN which_WDT recognizes_VBZ an_DT epitope_NN in_IN the_DT
          conserved_JJ C-_NNP terminal_NN domain_NN and_CC monoclonal_NN antibody_NN 32_CD TA_NNP
          raised_VBD against_IN peptide_NN P_NN 1_CD in_IN the_DT N-_NNP terminal_NN region_NN as_IN
          described_VBN in_IN [_NN 5_CD ]_NN ._. TAF_NNP 
          II_NNP 100_CD ,_, TAF_NNP 
          II_NNP 55_CD ,_, TAF_NNP 
          II_NNP 30_CD ,_, and_CC TAF_NNP 
          II_NNP 20_CD ,_, were_VBD detected_VBN using_VBG the_DT
          previously_RB described_VBN monoclonal_NN antibodies_NNS (_( [_NN 4_CD ,_, 69_CD ,_, 70_CD ]_NN
          and_CC refs_NNS therein_RB )_) ._. RARγ_NNP 2_CD was_VBD detected_VBN using_VBG the_DT
          previously_RB described_VBN antibody_NN [_NN 42_CD ]_NN ._. Anti-flag_NNP monoclonal_NN
          antibody_NN was_VBD puchased_JJ from_IN Sigma_NNP ._. Blots_NNP were_VBD revealed_VBN
          using_VBG peroxidase_NN conjugated_JJ goat_NN anti-mouse_JJ IgG_NNP antibody_NN
          and_CC chemiluminescence_NN with_IN an_DT ECL_NNP kit_NN (_( Amersham_NNP )_) ._.
          Protease_NNP inhibitors_NNS MG_NNP 132_CD (_( Cbz-leu-leu-leucinal_NNP )_) and_CC ALLN_NNP
          (_( acetyl-leu-leu-norleucinal_JJ )_) were_VBD purchased_VBN from_IN
          CalBiochem_NNP and_CC ICN_NNP Biochemicals_NNP respectively_RB ._. Each_DT was_VBD
          resuspended_JJ in_IN DMSO_NNP and_CC added_VBD to_TO cells_NNS or_CC extracts_NNS at_IN a_DT
          final_JJ concentration_NN of_IN 50_CD μM_NN ._.
        
        
          RT-PCR_NNP and_CC flow_NN cytometry_NN
          Total_JJ cellular_JJ RNA_NNP was_VBD isolated_VBN using_VBG Trizol_NNP Reagent_NNP
          (_( Life_NNP Technologies_NNPS )_) from_IN F_NN 9_CD cells_NNS grown_VBN in_IN parallel_JJ with_IN
          those_DT used_VBN for_IN making_VBG protein_NN extracts_NNS ._. 1_LS μg_NN of_IN total_JJ RNA_NNP
          was_VBD then_RB analysed_JJ by_IN RT-PCR_NNP performed_VBD as_IN described_VBN [_NN 50_CD ]_NN
          Control_NNP reactions_NNS (_( not_RB shown_VBN )_) contained_VBD all_DT components_NNS
          except_IN reverse_NN transcriptase_NN ._. Details_NNS of_IN the_DT
          exon-specific_JJ primers_NNS for_IN HPRT_NNP ,_, TBP_NNP ,_, and_CC TAF_NNP 
          II_NNP 135_CD ,_, are_VBP available_JJ upon_IN request_NN ._.
          The_DT primers_NNS used_VBN for_IN RARβ_NNP 2_CD ,_, laminin_NN B_NNP 1_CD and_CC collagen_NN IVa_NNP 1_CD
          were_VBD as_RB previously_RB described_VBD [_NN 49_CD ]_NN ._. Southern_NNP blotting_VBG and_CC
          hybridisation_NN for_IN RARβ_NNP 2_CD were_VBD performed_VBN by_IN standard_JJ
          procedures_NNS ._. Flow_NNP cytometry_NN was_VBD performed_VBN as_IN described_VBN by_IN
          Metzger_NNP et_CC al_NN ._. ,_, (_( 1999_CD )_) using_VBG a_DT final_JJ concentration_NN of_IN 25_CD
          μg_NN /_NN ml_NN of_IN propidium_NN iodide_NN and_CC FITC-labelled_NNP annexin_NN V_NNP
          (_( CALTAG_NNP Laboratories_NNPS )_) ._. Samples_NNP were_VBD analysed_JJ on_IN a_DT FACScan_NNP
          (_( Becton_NNP Dickinson_NNP )_) equipped_VBN with_IN a_DT single_JJ aron_NN laser_NN ._. A_DT
          minimum_NN of_IN 10_CD 5_CD cells_NNS per_IN sample_NN were_VBD analysed_JJ with_IN the_DT
          CELLQuest_NNP software_NN ._.
        
      
    
  
